Amedeo Smart

Free Medical Literature Service

 

Amedeo

Dermatology
  Free Subscription

Articles published in
Br J Dermatol
    May 2025
  1. POWELL JB, Dhesi JK, Harwood CA, McGrath EJ, et al
    How do we avoid over-treating skin cancer in people with severe frailty and limited life expectancy?
    Br J Dermatol. 2025 May 15:ljaf174. doi: 10.1093.
    >> Share

  2. DA ROSA GP, Santos JV, Cerejeira A, Matos P, et al
    Patterns of hospitalizations due to bacterial skin and soft tissue infections: a retrospective observational study from a Portuguese national registry.
    Br J Dermatol. 2025 May 15:ljaf157. doi: 10.1093.
    >> Share

  3. DOELEMAN T, Beljaards ESM, Ottevanger R, Jansen P, et al
    Added value of pathology consultations in cutaneous lymphomas: a 2-year review from the Dutch national referral and expertise centre.
    Br J Dermatol. 2025 May 14:ljaf184. doi: 10.1093.
    >> Share

  4. CHEN JQ, Zheng M, Yin WH, Wang P, et al
    Safety and efficacy of the selective TYK2/JAK1 inhibitor TLL-018 in moderate-to-severe plaque psoriasis: A phase 1b, randomized, double-blind, placebo-controlled study.
    Br J Dermatol. 2025 May 14:ljaf185. doi: 10.1093.
    >> Share

  5. ARMSTRONG AW, Blauvelt A, Lebwohl M, Asahina A, et al
    Efficacy and safety of tildrakizumab in patients with early- vs late-onset psoriasis.
    Br J Dermatol. 2025 May 14:ljaf171. doi: 10.1093.
    >> Share

  6. YANG HW, Chen YH, To SY, Wen YL, et al
    Hormone Therapy and Increased Risk of Psoriasis in Reproductive-age and Postmenopausal Women: A Nationwide Cohort Study and Target Trial Emulation.
    Br J Dermatol. 2025 May 9:ljaf179. doi: 10.1093.
    >> Share

  7. WANG Y, Xu G, Xia H
    Targeting the MAPK Pathway for NRAS Mutant Melanoma: From Mechanism to Clinic.
    Br J Dermatol. 2025 May 9:ljaf178. doi: 10.1093.
    >> Share

  8. DRUCKER AM, Walwyn C, Chu C, Yiu ZZN, et al
    Living network meta-analysis to compare nemolizumab against other available targeted systemic treatments for atopic dermatitis.
    Br J Dermatol. 2025 May 7:ljaf166. doi: 10.1093.
    >> Share

  9. WHITEMAN DC
    Melanoma in England: incidence is up, mortality is down.
    Br J Dermatol. 2025 May 7:ljaf175. doi: 10.1093.
    >> Share

  10. MORTIMORE AM, McMeniman E
    Reassuring results from skin cancer risk in Swedish patients with vitiligo and alopecia areata.
    Br J Dermatol. 2025 May 6:ljaf118. doi: 10.1093.
    >> Share

  11. FOWLER JC, Sood RK, Coltart G, Lai C, et al
    The mutation burden of narrowband ultraviolet B phototherapy (NB-UVB) in human skin; relevance to NB-UVB lifetime exposures and skin cancer surveillance.
    Br J Dermatol. 2025 May 3:ljaf173. doi: 10.1093.
    >> Share

  12. KIRCIK L, Tsianakas A, Valenzuela F, Mikol V, et al
    Efficacy and Safety of Rilzabrutinib in Patients With Moderate-to-Severe Atopic Dermatitis: 16-Week Results From a Proof-of-Concept Phase II Clinical Trial.
    Br J Dermatol. 2025 May 3:ljaf156. doi: 10.1093.
    >> Share

  13. ZHANG WW, Ke LF, Chen Y, Wu CY, et al
    Methylation-Based Test for Diagnosis of Benign and Malignant Melanocytoma.
    Br J Dermatol. 2025 May 2:ljaf169. doi: 10.1093.
    >> Share

  14. GILLESPIE J, Bash GN, Jacobson ME, Latour E, et al
    Harmonizing Measurement of Eczema Control- Mapping Scores Between the Atopic Dermatitis Control Tool and The Recap of Atopic Eczema Instrument.
    Br J Dermatol. 2025 May 2:ljaf167. doi: 10.1093.
    >> Share

  15. LU G, Chambers S, Cepica T, Xie L, et al
    Erythema and scale in cutaneous lupus erythematosus significantly impacts patient quality of life and disease course impression.
    Br J Dermatol. 2025 May 2:ljaf165. doi: 10.1093.
    >> Share

    April 2025
  16. JIANG X, Mortlock RD, Lomakin IB, Zhou J, et al
    Autosomal dominant SLURP1 variants cause palmoplantar keratoderma and progressive symmetric erythrokeratoderma.
    Br J Dermatol. 2025;192:896-906.
    >> Share

  17. PATHMARAJAH P, Eid E, Nazaroff J, So J, et al
    Functional genotype classification groups distinguish disease severity in recessive dystrophic epidermolysis bullosa.
    Br J Dermatol. 2025;192:917-925.
    >> Share

  18. SCHELL SL, Sennett ML, Feehan RP, Wallace TE, et al
    Pilot study of topical ruxolitinib demonstrates efficacy and blunting of heterogeneous inflammatory processes in mild hidradenitis suppurativa.
    Br J Dermatol. 2025;192:845-856.
    >> Share

  19. LIU Y, Liu Z, Li D, He X, et al
    Emerging role of regulatory T cells in the immunopathogenesis of vitiligo and implications for treatment.
    Br J Dermatol. 2025;192:796-806.
    >> Share

  20. SILVERBERG JI, Dodiuk-Gad R, Takaoka R, Tan J, et al
    Atopic dermatitis starting in childhood has a stronger impact on adults: results from the "Scars of Life" international project in 27 countries.
    Br J Dermatol. 2025 Apr 26:ljaf158. doi: 10.1093.
    >> Share

  21. LEMARCQ L, Reynaert V, Van den Steen E, Evers-Lebrun C, et al
    Outcome Measures for Interdisciplinary Care in Immune-mediated Inflammatory Skin Diseases (skIMIDs): A Scoping Review.
    Br J Dermatol. 2025 Apr 18:ljaf153. doi: 10.1093.
    >> Share

  22. NASLUND-KOCH C, Kvist-Hansen A, Bojesen SE, Skov L, et al
    Low-grade systemic inflammation is associated with risk of psoriasis in a general population study of more than 100,000 individuals.
    Br J Dermatol. 2025 Apr 18:ljaf147. doi: 10.1093.
    >> Share

  23. DUGOURD PM, Guardoli D, Fontas E, Marie-Luce S, et al
    Promoting Repigmentation after Epidermal cell suspension grafting and preVENTing the loss of melanocytes using topical ruxolitinib for vitiligo in resistant areas (PREVENT). A prospective monocentric interventional double-blind study.
    Br J Dermatol. 2025 Apr 17:ljaf143. doi: 10.1093.
    >> Share

  24. FARIYIKE O, Johnson NA, Van Bodegraven B, Quirke K, et al
    The role of limited life expectancy in personalised treatment decisions: 1 in 6 patients aged 80+ with a basal cell carcinoma die within 2 years of diagnosis in England.
    Br J Dermatol. 2025 Apr 15:ljaf135. doi: 10.1093.
    >> Share

  25. ZHU J, Abuabara K
    Complex comorbidities: Could a diabetes drug help prevent atopic dermatitis?
    Br J Dermatol. 2025 Apr 15:ljaf131. doi: 10.1093.
    >> Share

  26. CHEN J, Liu X, Bai Y, Tang X, et al
    Tonsillar Microbiota Alterations Contribute to Immune Responses in Psoriasis by Skewing Aged Neutrophils.
    Br J Dermatol. 2025 Apr 15:ljaf134. doi: 10.1093.
    >> Share

  27. KARPONIS D, van Bodegraven B, Mistry K, Nikolaou V, et al
    Incidence and mortality of melanoma in situ and malignant melanoma in England between 2001 and 2020.
    Br J Dermatol. 2025 Apr 15:ljaf136. doi: 10.1093.
    >> Share

  28. PILERI A, Zengarini C
    Harnessing Extracorporeal Photopheresis to Trigger Immunogen Cell Death: A Bounty on Cutaneous Lymphoma Cells.
    Br J Dermatol. 2025 Apr 12:ljaf138. doi: 10.1093.
    >> Share

  29. HUAI P, Xing P, Yang Y, Kong Y, et al
    Global burden of skin and subcutaneous diseases: an update from the Global Burden of Disease Study 2021.
    Br J Dermatol. 2025 Apr 11:ljaf071. doi: 10.1093.
    >> Share

  30. FALTOT L, Donzel M, Chidiac G, Balme B, et al
    Evaluation of the anti-CCR4 monoclonal antibody Mogamulizumab in advanced cutaneous T-cell lymphomas and with large cell transformation.
    Br J Dermatol. 2025 Apr 7:ljaf125. doi: 10.1093.
    >> Share

  31. WANG J, Hennessey D, Iyer A, O'Keefe S, et al
    Transcriptomic skin niches in systemic sclerosis underpins a role for mitochondrial dysfunction.
    Br J Dermatol. 2025 Apr 2:ljaf119. doi: 10.1093.
    >> Share

  32. ISKANDAR RJ, Tadrous M, Nguyen P, Dolovich L, et al
    Characteristics of patients seeking skin-related minor ailment pharmacy services in Ontario, Canada: A population-based cross-sectional study.
    Br J Dermatol. 2025 Apr 2:ljaf092. doi: 10.1093.
    >> Share

  33. SARASWAT N, Tripathy DM, Adhau RW, Tripathy A, et al
    Furuncular Myiasis in the skin of colour.
    Br J Dermatol. 2025 Apr 1:ljaf114. doi: 10.1093.
    >> Share

    March 2025
  34. ALEXANDER H, Murryam S, Kezic S, Motazedi E, et al
    Methotrexate and Cyclosporin Improve Skin Biomarkers in Paediatric Atopic Dermatitis: Results from the TREatment of Severe Atopic Eczema Trial.
    Br J Dermatol. 2025 Mar 27:ljaf115. doi: 10.1093.
    >> Share

  35. VESTERGAARD C
    Air Pollution and Atopic Dermatitis: Critical Windows of Risk in Early Life.
    Br J Dermatol. 2025 Mar 24:ljaf109. doi: 10.1093.
    >> Share

  36. BAGOT M
    Therapeutic advances for Cutaneous T Cell Lymphoma.
    Br J Dermatol. 2025 Mar 22:ljaf105. doi: 10.1093.
    >> Share

  37. LACKNER A, Burner T, Brandner M, Dey S, et al
    Evidence of Immunogenic Cell Death (ICD) and ICD-dependent Dendritic Cell Activation Induced by Extracorporeal Photopheresis in Patients with leukemic forms of cutaneous T cell lymphoma.
    Br J Dermatol. 2025 Mar 20:ljaf102. doi: 10.1093.
    >> Share

  38. LEE CN, Hsieh MH, Chen CY, Yang CC, et al
    Risk of Herpes Zoster and Postherpetic Neuralgia in Patients with Psoriasis Treated with Biologics: A nationwide study using target trial emulation framework.
    Br J Dermatol. 2025 Mar 20:ljaf101. doi: 10.1093.
    >> Share

  39. DE LA IGLESIA MARTIN J, Martin Vera J, Tubau Prims C
    Dermatitis cruris pustulosa et atrophicans.
    Br J Dermatol. 2025 Mar 20:ljaf103. doi: 10.1093.
    >> Share

  40. AHMADY S, Mosterd K, Jansen MHE, Kelleners-Smeets NWJ, et al
    Patient preferences for the treatment of Bowen disease.
    Br J Dermatol. 2025;192:653-659.
    >> Share

  41. KIMBALL AB, Bechara FG, Badat A, Giamarellos-Bourboulis EJ, et al
    Long-term efficacy and safety of secukinumab in patients with moderate-to-severe hidradenitis suppurativa: week 104 results from the SUNSHINE and SUNRISE extension trial.
    Br J Dermatol. 2025;192:629-640.
    >> Share

  42. LEAR JT, Harwood CA, Hasan Z, Kentley J, et al
    Topical application of the Hedgehog inhibitor patidegib in patients with Gorlin syndrome: a phase II trial.
    Br J Dermatol. 2025;192:611-617.
    >> Share

  43. RASTRICK J, Edwards H, Ferecsko AS, Le Friec G, et al
    The roles of interleukin (IL)-17A and IL-17F in hidradenitis suppurativa pathogenesis: evidence from human in vitro preclinical experiments and clinical samples.
    Br J Dermatol. 2025;192:660-671.
    >> Share

  44. HUA VK, Chang J, Laxer RM, Broderick L, et al
    Disabling pansclerotic morphoea: a century of discovery.
    Br J Dermatol. 2025;192:585-596.
    >> Share

  45. WALBURN J, Norton S, Sarkany R, Canfield M, et al
    A personalized and systematically designed adherence intervention improves photoprotection in adults with xeroderma pigmentosum (XP): results of the XPAND randomized controlled trial.
    Br J Dermatol. 2025;192:728-737.
    >> Share

  46. NAKAMIZO S, Kabashima K
    Cutaneous Granulomas: Mechanisms, Cellular Interactions, and Therapeutic Insights.
    Br J Dermatol. 2025 Mar 13:ljaf096. doi: 10.1093.
    >> Share

  47. MIRANDA BH, Shahid S, Correiro A, Zhang J, et al
    St Andrews Referral Delay in Skin Cancer (StARDISC): A study of keratinocyte skin cancer time to treatment, growth, invasiveness, British Association of Dermatologists risk factors and excision adequacy.
    Br J Dermatol. 2025 Mar 13:ljaf097. doi: 10.1093.
    >> Share

  48. LI T, Tao R, Yang L, Wan Z, et al
    Upadacitinib outperforms dupilumab in restoring the fungal microbiome in atopic dermatitis.
    Br J Dermatol. 2025 Mar 12:ljaf095. doi: 10.1093.
    >> Share

  49. SU T, Yu Y, Su Z, Lu Y, et al
    Rapid improvements in Kaposi sarcoma with metformin: a report of two cases.
    Br J Dermatol. 2025 Mar 11:ljaf090. doi: 10.1093.
    >> Share

  50. ZHANG Q, Liu G, Jing L, Aghayants S, et al
    The Landscape of m6A RNA Methylation in Skin Diseases.
    Br J Dermatol. 2025 Mar 10:ljaf087. doi: 10.1093.
    >> Share

  51. WEN YL, Hsu WT, Chen YH, Kao HH, et al
    Sodium-glucose Cotransporter 2 Inhibitors and Inverse Risk of New-onset Atopic Dermatitis in Diabetic Population: a Nationwide, Active-comparator Study.
    Br J Dermatol. 2025 Mar 4:ljaf086. doi: 10.1093.
    >> Share

  52. KOCHI Y, Togawa Y, Yamazaki Y, Yamamoto Y, et al
    Anatomical distribution of acral lentiginous melanoma in the hand and nail among Japanese individuals.
    Br J Dermatol. 2025 Mar 4:ljaf070. doi: 10.1093.
    >> Share

  53. VON SCHUCKMANN LA, Khosrotehrani K
    Haematological cancers and skin cancer: statistics from the Netherlands.
    Br J Dermatol. 2025 Mar 1:ljaf081. doi: 10.1093.
    >> Share

    February 2025
  54. COSTANZA M, Giordano C, von Brunneck AC, Zhao J, et al
    Preclinical in vitro and in vivo evidence for CD74-targeting as effective treatment strategy for cutaneous T cell lymphomas.
    Br J Dermatol. 2025 Feb 27:ljaf001. doi: 10.1093.
    >> Share

  55. ACKERMANN DM, Bell KJL
    Setting the melanoma research agenda for all end-users: the need to include patient, clinician, and policy perspectives.
    Br J Dermatol. 2025 Feb 27:ljaf082. doi: 10.1093.
    >> Share

  56. NARDIN C, Vernerey D, Aubin F
    Ipilimumab + nivolumab combination or nivolumab monotherapy as first-line treatment in patients with metastatic melanoma: conclusions from a real-world French national cohort.
    Br J Dermatol. 2025 Feb 27:ljaf080. doi: 10.1093.
    >> Share

  57. MISTRY K, Srimudkul O, Patel M, Ragan J, et al
    Patient research priorities in melanoma: a national qualitative interview study.
    Br J Dermatol. 2025 Feb 27:ljaf048. doi: 10.1093.
    >> Share

  58. ROY SF, Agim NG, Mir A, Couts KL, et al
    Congenital melanocytic nevi initiated by BRAF fusion oncogene with firmness, pruritus, and desmoplastic stroma.
    Br J Dermatol. 2025 Feb 27:ljaf061. doi: 10.1093.
    >> Share

  59. LIN LH, Lee CC, Hwang MM, Jung CR, et al
    Fine particulate matter exposure and incident atopic dermatitis: A birth cohort study.
    Br J Dermatol. 2025 Feb 26:ljaf075. doi: 10.1093.
    >> Share

  60. KROAH-HARTMAN M, Lee JYW, Dooley N, Tan WR, et al
    Environmental triggers of psoriasis: insights from a UK patient-reported cohort (mySkin).
    Br J Dermatol. 2025 Feb 25:ljaf073. doi: 10.1093.
    >> Share

  61. DELCOIGNE B, Lysell J, Askling J
    Incidence, stage and outcome of melanoma, keratinocyte and other cancers in individuals with vitiligo or alopecia: intraindividual or familial risks?
    Br J Dermatol. 2025 Feb 25:ljaf074. doi: 10.1093.
    >> Share

  62. OTTEVANGER R, Vermeer MH
    Cutaneous T-cell lymphoma in Australia: what drives geospatial?
    Br J Dermatol. 2025 Feb 22:ljaf026. doi: 10.1093.
    >> Share

  63. WANG Z, Liu J, Wechsberg O, Liang L, et al
    Variants in KLF4 affecting residue Asp441 cause an autosomal dominant syndromic ichthyosis.
    Br J Dermatol. 2025 Feb 19:ljaf062. doi: 10.1093.
    >> Share

  64. PERIS K
    Patidegib: a novel, promising treatment for basal cell carcinoma lesions in patients with Gorlin syndrome.
    Br J Dermatol. 2025 Feb 19:ljae515. doi: 10.1093.
    >> Share

  65. GNIADECKI R, Guenova E, Querfeld C, Nicolay JP, et al
    Haematogenous seeding in mycosis fungoides and Sezary syndrome: current evidence and clinical implications.
    Br J Dermatol. 2025;192:381-389.
    >> Share

  66. PHILIPP-DORMSTON WG, Bruckner M, Hoffmann M, Bae M, et al
    Artificial daylight photodynamic therapy using methyl aminolaevulinate in a real-world setting in Germany: results from the noninterventional study ArtLight.
    Br J Dermatol. 2025;192:510-519.
    >> Share

  67. WEHKAMP U, Pietzka S, Kotrova M, Jost M, et al
    Mycosis fungoides: differentiation from inflammation and detection of circulating tumour cells with the EuroClonality next-generation sequencing assay.
    Br J Dermatol. 2025;192:492-500.
    >> Share

  68. DONHAUSER T, Gabes M, Masur C, Kamudoni P, et al
    Longitudinal validity of the Hyperhidrosis Quality of Life Index (HidroQoL(c)) in a phase IIIb clinical trial population with hyperhidrosis: responsiveness and meaningful change.
    Br J Dermatol. 2025;192:450-457.
    >> Share

  69. SWIDERSKI M, Vinogradova Y, Knaggs RD, Harman K, et al
    Association between drugs and vaccines commonly prescribed to older people and bullous pemphigoid: a case-control study.
    Br J Dermatol. 2025;192:440-449.
    >> Share

  70. KIM SR, Koh SJ, Park H
    Association of childhood obesity or weight change with early-onset follicular occlusion triad in children.
    Br J Dermatol. 2025;192:430-439.
    >> Share

  71. PLANELLA-FONTANILLAS N, Bosch-Amate X, Jimenez Anton A, Moreno-Vilchez C, et al
    Real-world evaluation of the effectiveness and safety of dupilumab in bullous pemphigoid: an ambispective multicentre case series.
    Br J Dermatol. 2025;192:501-509.
    >> Share

  72. SZONDI DC, Crompton RA, Oon L, Subramaniam N, et al
    A role for Arginase in skin epithelial differentiation and anti-microbial peptide production.
    Br J Dermatol. 2025 Feb 14:ljaf057. doi: 10.1093.
    >> Share

  73. ZOUBOULIS CC, Deloche C, Skayem C, Leclerc-Mercier S, et al
    Global study of 17,009 women reveal significant skin condition changes associated with irregular menstrual cycles.
    Br J Dermatol. 2025 Feb 11:ljae484. doi: 10.1093.
    >> Share

  74. LOPEZ S, Thakker S, Minkis K
    Beyond the Diagnosis: A Skin of Color Patient's Journey with Acral Lentiginous Melanoma.
    Br J Dermatol. 2025 Feb 6:ljaf047. doi: 10.1093.
    >> Share

  75. VON KOBYLETZKI L, Svensson A
    Patient-reported outcome measures are highly needed for patients with skin of colour with atopic dermatitis.
    Br J Dermatol. 2025 Feb 4:ljaf043. doi: 10.1093.
    >> Share

  76. FREW JW
    Unravelling the complex pathogenesis of hidradenitis suppurativa.
    Br J Dermatol. 2025;192.
    >> Share

  77. PETUKHOVA L, Colvin A, Koerts NDK, Horvath B, et al
    Leveraging genotypes and phenotypes to implement precision medicine in hidradenitis suppurativa management.
    Br J Dermatol. 2025;192.
    >> Share

  78. SAYED CJ, Shams RB, Midgette B, Garg A, et al
    An evolutionary tale on clinical trials in hidradenitis suppurativa.
    Br J Dermatol. 2025;192.
    >> Share

    January 2025
  79. LEDUCQ S, Fong WCG, Williams HC, Bradshaw L, et al
    Reporting of concomitant and rescue topical therapies in atopic dermatitis randomised controlled trials evaluating a systemic treatment: a scoping review.
    Br J Dermatol. 2025 Jan 30:ljaf031. doi: 10.1093.
    >> Share

  80. ALVES C
    Orismilast for moderate-to-severe atopic dermatitis: the potential therapeutic value of a new oral pharmacological alternative.
    Br J Dermatol. 2025 Jan 30:ljaf042. doi: 10.1093.
    >> Share

  81. GNIADECKI R
    Chaperoning a Cure: Unexpected Role of CD74 in Cutaneous T-cell lymphoma.
    Br J Dermatol. 2025 Jan 29:ljaf040. doi: 10.1093.
    >> Share

  82. KANEDA E, Koguchi-Yoshioka H, Nimura K, Hattori S, et al
    Genotype-phenotype correlation for skin and neuropsychiatric features in tuberous sclerosis complex.
    Br J Dermatol. 2025 Jan 28:ljaf038. doi: 10.1093.
    >> Share

  83. WARREN RB, Lebwohl M, Thaci D, Gooderham M, et al
    Bimekizumab efficacy and safety through 3 years in patients with moderate to severe plaque psoriasis: Long-term results from the BE RADIANT phase 3b trial open-label extension period.
    Br J Dermatol. 2025 Jan 25:ljaf032. doi: 10.1093.
    >> Share

  84. PILIANG M, Soung J, King B, Shapiro J, et al
    Efficacy and safety of the oral Janus kinase 3/tyrosine kinase expressed in hepatocellular carcinoma family kinase inhibitor ritlecitinib over 24 months: integrated analysis of the ALLEGRO phase IIb/III and long-term phase III clinical studies in alop
    Br J Dermatol. 2025;192:215-227.
    >> Share

  85. GARG A, Burge R, Cohee A, Wallinger H, et al
    Validation of the real-world application of the Hidradenitis Suppurativa Quality of Life (HiSQOL) score to adults with hidradenitis suppurativa.
    Br J Dermatol. 2025;192:261-268.
    >> Share

  86. ZHU Z, Zhong X, Luo Z, Liu M, et al
    Global, regional and national burdens of acne vulgaris in adolescents and young adults aged 10-24 years from 1990 to 2021: a trend analysis.
    Br J Dermatol. 2025;192:228-237.
    >> Share

  87. PERALS C, le Jan S, Muller C, Le Naour R, et al
    Polarization of circulating follicular helper T cells correlates with bullous pemphigoid severity.
    Br J Dermatol. 2025;192:283-292.
    >> Share

  88. EGGERMONT CJ, Hollatz A, Wakkee M, Louwman M, et al
    Skin cancer risk in over 200.000 patients with haematologic malignancies in 30 years; a nationwide population-based study in the Netherlands.
    Br J Dermatol. 2025 Jan 24:ljaf027. doi: 10.1093.
    >> Share


  89. Correction to: Microbiome characterization of skin biopsies in Spanish patients with hidradenitis suppurativa shows a decrease in D1 and H1 lineages of Cutibacterium acnes.
    Br J Dermatol. 2025 Jan 24:ljaf029. doi: 10.1093.
    >> Share

  90. BARKER JN, Casanova E, Choon SE, Foley P, et al
    Global Delphi consensus on treatment goals for generalised pustular psoriasis.
    Br J Dermatol. 2025 Jan 23:ljae491. doi: 10.1093.
    >> Share

  91. SMITH MJ, Peach H, Keohane S, Lear J, et al
    Melanoma: Assessment and Management summary of 2022 update of the NICE guidelines.
    Br J Dermatol. 2025 Jan 21:ljaf016. doi: 10.1093.
    >> Share

  92. ANDERSON ADG, Shirwac HF, Morgan H, Greenish H, et al
    Real-World Melanoma Miss-Rate In An NHS Hospital Dermatology Service. A Retrospective Study.
    Br J Dermatol. 2025 Jan 16:ljaf024. doi: 10.1093.
    >> Share

  93. ALABAS OA, Mason KJ, Yiu ZZN, Smith CH, et al
    Age and biologic survival in patients with moderate-to-severe psoriasis: A cohort study from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR).
    Br J Dermatol. 2025 Jan 10:ljaf017. doi: 10.1093.
    >> Share

  94. HARTFORD C, Alexis A, Wang Z, Levit NA, et al
    Development of novel patient-reported outcome instruments to assess atopic dermatitis-associated dyspigmentation and xerosis in patients with skin of colour.
    Br J Dermatol. 2025 Jan 10:ljae494. doi: 10.1093.
    >> Share

  95. PUIG L
    Post-switching discontinuation of biosimilars in psoriasis: registry analyses fall short in addressing real-world biases.
    Br J Dermatol. 2025 Jan 7:ljaf003. doi: 10.1093.
    >> Share

  96. CHENG JW, Li JH
    Squamous cell carcinoma arising from lichen planus.
    Br J Dermatol. 2025 Jan 7:ljaf007. doi: 10.1093.
    >> Share

  97. MCGRATH JA, Kabashima K
    Unlocking the skin's immunological secrets: antibodies and new topical vaccination strategies.
    Br J Dermatol. 2025 Jan 7:ljaf014. doi: 10.1093.
    >> Share

  98. SILVERBERG JI, Eichenfield LF, Blauvelt A, Irvine AD, et al
    Orismilast, a PDE4B/D inhibitor, in moderate-to-severe atopic dermatitis: Efficacy and safety from a multicenter, randomized, placebo-controlled, phase 2b dose-ranging study (ADESOS).
    Br J Dermatol. 2025 Jan 7:ljae507. doi: 10.1093.
    >> Share

    December 2024
  99. PLACKE JM, Bottek J, Varaljai R, Shannan B, et al
    Spatial proteomics reveals sirtuin 1 to be a determinant of T-cell infiltration in human melanoma.
    Br J Dermatol. 2024 Dec 31:ljae433. doi: 10.1093.
    >> Share

  100. PATRA V, Wolf P
    Skin microbiome and polymorphous light eruption.
    Br J Dermatol. 2024 Dec 26:ljae513. doi: 10.1093.
    >> Share

  101. TAKASE K, Komatsu-Fujii T, Kogame T, Otsuka A, et al
    Tinea corporis at the injection site of interleukin-17 inhibitor in psoriasis vulgaris.
    Br J Dermatol. 2024 Dec 26:ljae511. doi: 10.1093.
    >> Share

  102. CHEN Z, Wang Y, Wang R
    Generalized granulomatous slack skin.
    Br J Dermatol. 2024 Dec 25:ljae508. doi: 10.1093.
    >> Share

  103. CARRASCOSA JM
    Optimizing dosing in atopic dermatitis therapy: Looking for the cream of the crop.
    Br J Dermatol. 2024 Dec 25:ljae514. doi: 10.1093.
    >> Share

  104. IWASAWA O, Ikegami M, Miyagawa T, Morita H, et al
    Association of genetic alterations with prognosis in extramammary Paget disease: insights into the involvement of somatic CDKN2A variants in patients with a poor prognosis.
    Br J Dermatol. 2024;192:46-54.
    >> Share

  105. BONTOUX C, Badrignans M, Afach S, Sbidian E, et al
    Pustular mycosis fungoides has a poor outcome: a multicentric clinicopathological and molecular case series.
    Br J Dermatol. 2024;192:125-134.
    >> Share

  106. ELEFTHERIADOU V, Ahmed A, Nesnas J, Nagra R, et al
    The lifetime risk and impact of vitiligo across sociodemographic groups: a UK population-based cohort study.
    Br J Dermatol. 2024;192:63-71.
    >> Share

  107. LI J, Wang Y, Niu X, Xing J, et al
    Downregulation of lysine 2-hydroxyisobutyrylation of ErbB3 binding protein 1 at amino acid 210 promotes keratinocyte proliferation via induction of transcription initiation factor IA-mediated rRNA synthesis.
    Br J Dermatol. 2024;192:92-103.
    >> Share


  108. Correction to: Severity rating of specific skin lesions in hidradenitis suppurativa: the patient perspective.
    Br J Dermatol. 2024 Dec 23:ljae474. doi: 10.1093.
    >> Share

  109. PRAJAPATI VH, Seyger MMB, Wilsmann-Theis D, Szakos E, et al
    Guselkumab for the treatment of moderate-to-severe plaque psoriasis in pediatric patients: results of the phase 3, randomized, placebo-controlled PROTOSTAR study.
    Br J Dermatol. 2024 Dec 21:ljae502. doi: 10.1093.
    >> Share

  110. PREIS S, Biedermann T, Zink A
    Unseen Spaces: Psoriasis Inversa Between the Toes.
    Br J Dermatol. 2024 Dec 21:ljae500. doi: 10.1093.
    >> Share

  111. BADAWY H, Harvey J, Rajan N, Stuart B, et al
    Changes in skin research funding: the emergence of environmental sustainability criteria in the research competition assessment process.
    Br J Dermatol. 2024 Dec 20:ljae503. doi: 10.1093.
    >> Share

  112. CHEN L, Tan M, Li T, Zhu L, et al
    Rapid and sustained response of stubborn guttate psoriasis to ustekinumab: A 52-week, two-center, one-arm, observational study.
    Br J Dermatol. 2024 Dec 18:ljae481. doi: 10.1093.
    >> Share

  113. WHITEMAN DC, Pandeya N, Olsen CM
    Differences in mean age at diagnosis of invasive melanoma for men and women, by anatomic site, thickness, and subtype.
    Br J Dermatol. 2024 Dec 17:ljae482. doi: 10.1093.
    >> Share

  114. MITRA R, Hale TK, Fitzsimons HL, Gray C, et al
    A novel three-dimensional model of Infantile Haemangioma.
    Br J Dermatol. 2024 Dec 17:ljae483. doi: 10.1093.
    >> Share

  115. LYNCH M
    Beyond the Algorithm: Ethical Challenges in AI-Driven Skin Cancer Diagnosis.
    Br J Dermatol. 2024 Dec 16:ljae490. doi: 10.1093.
    >> Share

  116. MORTATO E, Talamonti M, Paganini C, Belcastro A, et al
    Comment on "A Practical Guide to Using Oral JAK Inhibitors for Atopic Dermatitis from the International Eczema Council"- A case of Rhabdomyolysis Induced by Upadacitinib.
    Br J Dermatol. 2024 Dec 13:ljae485. doi: 10.1093.
    >> Share

  117. LOUVEAU B, Jouenne F, Ram-Wolff C, Mancini M, et al
    Comment on 'Oncogenic alterations in KIR3DL1 in cutaneous acral CD8+ lymphoproliferative disorder' by Wobser et al.
    Br J Dermatol. 2024 Dec 13:ljae487. doi: 10.1093.
    >> Share

  118. DOUSSET L, Khosrotehrani K
    A new frontier in drug discovery for skin cancer through electronic medical records.
    Br J Dermatol. 2024 Dec 13:ljae489. doi: 10.1093.
    >> Share

  119. BERESFORD-WYLIE B, Ashcroft S, Gaglani B, Green A, et al
    Integrating artificial intelligence into skin cancer pathways; the opportunities and obstacles.
    Br J Dermatol. 2024 Dec 11:ljae480. doi: 10.1093.
    >> Share

  120. CHO SI, Na JI
    Long-term observation to determine durable efficacy and safety of novel paediatric atopic dermatitis treatment, nemolizumab.
    Br J Dermatol. 2024 Dec 10:ljae479. doi: 10.1093.
    >> Share

  121. SINKKO H, Olah P, Yang Y, Maia G, et al
    Taxonomic and functional profiling of skin microbiome in psoriasis.
    Br J Dermatol. 2024 Dec 9:ljae471. doi: 10.1093.
    >> Share

  122. SHAH SFH, O'Toole EA
    Biologics in Congenital Ichthyosis - an Incomplete Fix.
    Br J Dermatol. 2024 Dec 6:ljae475. doi: 10.1093.
    >> Share

  123. CAMPBELL BA, Baade PD, Dasgupta P, Cameron JK, et al
    Geospatial analyses demonstrate variation of cutaneous T-cell lymphomas across Australia, providing insights into possible causes.
    Br J Dermatol. 2024 Dec 6:ljae476. doi: 10.1093.
    >> Share

  124. WEIDINGER S, Bewley A, Hong HC, Silvestre JF, et al
    Predicting success with reduced dosing frequency of tralokinumab in patients with moderate-to-severe atopic dermatitis.
    Br J Dermatol. 2024 Dec 5:ljae439. doi: 10.1093.
    >> Share

  125. MCGRATH JA
    Recently discovered roles for macrophages in human skin development.
    Br J Dermatol. 2024 Dec 4:ljae473. doi: 10.1093.
    >> Share

    November 2024
  126. IGARASHI A, Katsunuma T, Nagano Y, Komazaki H, et al
    Long-term (68 weeks) administration of nemolizumab in paediatric patients aged 6-12 years with atopic dermatitis with moderate-to-severe pruritus: efficacy and safety data from a phase III study.
    Br J Dermatol. 2024 Nov 28:ljae458. doi: 10.1093.
    >> Share

  127. KARINE B, Mortier L, Dereure O, Dalac S, et al
    The efficacy and safety of first-line metastatic melanoma treatment with ipilimumab + nivolumab versus nivolumab in a real-world setting.
    Br J Dermatol. 2024 Nov 28:ljae470. doi: 10.1093.
    >> Share

  128. WOLBER AK, Jayasinghe D, Betz-Stablein B, Janda M, et al
    Incidence and patterns of newly developed pigmented lesions in adults at high risk for melanoma.
    Br J Dermatol. 2024 Nov 26:ljae467. doi: 10.1093.
    >> Share

  129. LI CY, Wang WT, Ma SH, Lo LW, et al
    Association of PCSK9 inhibitors with risk of nonmelanoma skin cancer: a retrospective cohort study.
    Br J Dermatol. 2024 Nov 25:ljae438. doi: 10.1093.
    >> Share

  130. AMAR Y, Niedermeier S, Silva R, Kublik S, et al
    Skin microbiome dynamics in patients with polymorphic light eruption in response to UV radiations.
    Br J Dermatol. 2024 Nov 22:ljae464. doi: 10.1093.
    >> Share

  131. ZHANG B, Mei J, Liao Q, Zhou S, et al
    Multitranscriptome analysis revealed that stromal cells in the papillary dermis promote angiogenesis in psoriasis vulgaris.
    Br J Dermatol. 2024 Nov 21:ljae459. doi: 10.1093.
    >> Share

  132. PHAN DB, Jourdain H, Descalzo-Gallego MA, Gonzalez-Quesada A, et al
    Drug Survival and Safety of Biosimilars Compared with Originator Adalimumab for Psoriasis: A Multinational Cohort Study.
    Br J Dermatol. 2024 Nov 20:ljae454. doi: 10.1093.
    >> Share

  133. THOMPSON AR, Tziotzios C, Nesnas J, Randall R, et al
    Lifetime incidence and healthcare disparities in alopecia areata: a UK population-based cohort study.
    Br J Dermatol. 2024;191:924-935.
    >> Share

  134. XIONG X, Cesarato N, Gossmann Y, Wehner M, et al
    A nonsense variant in KRT31 is associated with autosomal dominant monilethrix.
    Br J Dermatol. 2024;191:979-987.
    >> Share

  135. PATTINSON R, Trialonis-Suthakharan N, Pickles T, Austin J, et al
    Measurement properties and interpretability of the Patient-Reported Impact of Dermatological Diseases (PRIDD) measure.
    Br J Dermatol. 2024;191:936-948.
    >> Share

  136. OUYANG F, Yang H, Di Z, Hu J, et al
    Life's Essential 8, genetic susceptibility and the risk of psoriatic disease: a prospective cohort study.
    Br J Dermatol. 2024;191:897-905.
    >> Share

  137. SINGH N, Schikowski T
    Interactive effect of genetic and environmental risk factors on Psoriasis: current evidence and future directives.
    Br J Dermatol. 2024 Nov 15:ljae450. doi: 10.1093.
    >> Share

  138. ZHENG DX, Jenkins RW
    Real-world data confirms limited efficacy of dual anti-PD-1 and CTLA-4 immune checkpoint blockade in acral lentiginous melanoma.
    Br J Dermatol. 2024 Nov 15:ljae445. doi: 10.1093.
    >> Share


  139. Correction to: COL10A1 expression distinguishes a subset of cancer-associated fibroblasts present in the stroma of high-risk basal cell carcinoma.
    Br J Dermatol. 2024 Nov 11:ljae440. doi: 10.1093.
    >> Share

  140. VAN DER WEYDEN L, Del Castillo Velasco-Herrera M, Cheema S, Wong K, et al
    Exploration of the mutational landscape of cutaneous leiomyoma confirms FH as a driver gene and identifies targeting purine metabolism as a potential therapeutic strategy.
    Br J Dermatol. 2024 Nov 7:ljae432. doi: 10.1093.
    >> Share

  141. VAN VEEN FCAP, Rossel SVJ, Steijlen PM, Moser A, et al
    The perceived quality of life in adult patients with inherited ichthyosis: a qualitative interview study.
    Br J Dermatol. 2024 Nov 7:ljae436. doi: 10.1093.
    >> Share

  142. SHAH SFH, Arecco D, Draper H, Tiribelli S, et al
    Ethical implications of artificial intelligence in skin cancer diagnostics: use-case analyses.
    Br J Dermatol. 2024 Nov 6:ljae434. doi: 10.1093.
    >> Share

  143. CHIU TM, Chen CB, Lu CW, Hui RC, et al
    CCR8/CCL1 and CXCR3/CXCL10 axis mediated memory T cell activations in recalcitrant drug-induced hypersensitivity patients.
    Br J Dermatol. 2024 Nov 6:ljae375. doi: 10.1093.
    >> Share

  144. TAYLOR MA, Yuan M, Wang S, North JP, et al
    A Case of Biologic-Resistant Hand Dermatitis Demonstrates Dual T2/T17 Transcriptomic Abnormalities and Responds to JAK Inhibition.
    Br J Dermatol. 2024 Nov 5:ljae430. doi: 10.1093.
    >> Share

  145. SANGERS TE, van Doorn R
    The usefulness of large language models for patient information on melanoma: challenges and opportunities.
    Br J Dermatol. 2024 Nov 1:ljae429. doi: 10.1093.
    >> Share

    October 2024
  146. WELLER RB, Gu J
    Ultraviolet radiation is not the major cause of melanoma mortality in the UK and sun exposure advice should be revised.
    Br J Dermatol. 2024 Oct 30:ljae426. doi: 10.1093.
    >> Share

  147. MAZEREEUW-HAUTIER J, Granier Tournier C, Hernandez-Martin A, Milesi S, et al
    Biologics in congenital ichthyosis: are they effective?
    Br J Dermatol. 2024 Oct 29:ljae420. doi: 10.1093.
    >> Share

  148. RAUWERDINK DJW, Hoogland Y, Schrader AMR, Potjer TP, et al
    Melanoma arising from pre-existing naevus in carriers of a germline CDKN2A pathogenic variant.
    Br J Dermatol. 2024 Oct 29:ljae417. doi: 10.1093.
    >> Share

  149. CHEN M, Gao L
    Carcinoid syndrome presenting as diffuse violaceous cutaneous flushing.
    Br J Dermatol. 2024 Oct 26:ljae424. doi: 10.1093.
    >> Share

  150. BLAUVELT A, Papp K, Trivedi M, Barragan C, et al
    Efficacy and safety of the ustekinumab biosimilar ABP 654 in patients with moderate-to-severe plaque psoriasis: a randomized, double-blinded, active-controlled, comparative clinical study over 52 weeks.
    Br J Dermatol. 2024 Oct 23:ljae402. doi: 10.1093.
    >> Share

  151. KATOH N, Tanaka A, Takahashi H, Shimizu R, et al
    Long-term management of moderate-to-severe atopic dermatitis with lebrikizumab and concomitant topical corticosteroids: a 68-week, randomized, double-blind, placebo-controlled phase III trial in Japan (ADhere-J).
    Br J Dermatol. 2024 Oct 23:ljae394. doi: 10.1093.
    >> Share

  152. YANG X, Li L, Zhu M
    Primary cutaneous Alternaria alstroemeriae infection.
    Br J Dermatol. 2024 Oct 23:ljae409. doi: 10.1093.
    >> Share

  153. MCGILLIVRAY E, Ashouri K, Chatziioannou E, Gallegos JAO, et al
    Combined PD-1 and CTLA-4 Blockade in an International Cohort of Patients with Acral Lentiginous Melanoma.
    Br J Dermatol. 2024 Oct 23:ljae401. doi: 10.1093.
    >> Share

  154. SILVERBERG JI, Bunick CG, Hong HC, Mendes-Bastos P, et al
    Efficacy and Safety of Upadacitinib vs Dupilumab in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: Week 16 results of an Open-label, Randomized, Efficacy Assessor-Blinded Head-to-Head Phase 3b/4 Study (Level Up).
    Br J Dermatol. 2024 Oct 23:ljae404. doi: 10.1093.
    >> Share

  155. ZHANG J, Ding Y, Wang P, Li L, et al
    Deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 inhibitor, in patients from China mainland, Taiwan, and South Korea with moderate to severe plaque psoriasis: a phase 3 randomized clinical trial.
    Br J Dermatol. 2024 Oct 22:ljae406. doi: 10.1093.
    >> Share

  156. BLANCHARD G, Atallah I, Blanchard M, Fehrenbacher B, et al
    Primary cutaneous T-cell lymphoma not otherwise specified (NOS) uncovering a novel RAB27A variant in Griscelli syndrome type 2.
    Br J Dermatol. 2024 Oct 21:ljae412. doi: 10.1093.
    >> Share

  157. BARBIERI JS
    Levelling up outcomes in atopic dermatitis through personalized dosing of upadacitinib.
    Br J Dermatol. 2024 Oct 19:ljae410. doi: 10.1093.
    >> Share

  158. KOBYLETZKI LBV, Svensson A
    Treatment for atopic dermatitis with JAK Inhibitors-useful recommendations from expert opinions.
    Br J Dermatol. 2024 Oct 19:ljae396. doi: 10.1093.
    >> Share

  159. WANG Q, Niu G, Liu Z, Toma MA, et al
    Circular RNA circASH1L(4,5) protects microRNA-129-5p from target-directed microRNA degradation in human skin wound healing.
    Br J Dermatol. 2024 Oct 18:ljae405. doi: 10.1093.
    >> Share

  160. CAMPBELL C, Mayatra JM, Neve AJ, Fletcher JM, et al
    Inflammasomes: emerging therapeutic targets in hidradenitis suppurativa?
    Br J Dermatol. 2024;191:670-679.
    >> Share

  161. KORTE EWH, Baardman R, Pool G, Duipmans JC, et al
    Navigating the diagnostic journey of epidermolysis bullosa: a qualitative study of the lived experiences and needs of parents and patients.
    Br J Dermatol. 2024;191:737-745.
    >> Share

  162. TSENG H, Stone C, Shulruf B, Murrell DF, et al
    Establishing minimal clinically important differences for the Pemphigus Disease Area Index.
    Br J Dermatol. 2024;191:823-831.
    >> Share

  163. SORENSEN SBT, Farkas DK, Vestergaard C, Schmidt SAJ, et al
    Urticaria and the risk of cancer: a Danish population-based cohort study.
    Br J Dermatol. 2024;191:706-712.
    >> Share

  164. YOSIPOVITCH G, Skayem C, Aroman MS, Taieb C, et al
    International study on prevalence of itch: examining the role of itch as a major global public health problem.
    Br J Dermatol. 2024;191:713-718.
    >> Share

  165. RUTKOWSKI D, Scholey R, Davies J, Pye D, et al
    Epidermal growth factor receptor/mitogen-activated kinase inhibitor treatment induces a distinct inflammatory hair follicle response that includes collapse of immune privilege.
    Br J Dermatol. 2024;191:791-804.
    >> Share

  166. BETTUZZI T, Welfringer-Morin A, Ingen-Housz-Oro S, Bataille P, et al
    Comparison of incidence, causes and prognosis of adult and paediatric epidermal necrolysis: a French population-based study.
    Br J Dermatol. 2024;191:698-705.
    >> Share

  167. XIONG Y, Xia Y, Zhang X, Jiang B, et al
    Joint exposure to multiple air pollutants, genetic risk, and incident psoriasis: a large-scale prospective cohort study.
    Br J Dermatol. 2024 Oct 12:ljae391. doi: 10.1093.
    >> Share

  168. KUMARI R, Apfelbacher CJ, Nelson-Piercy C, Flohr C, et al
    The management of atopic dermatitis in women of childbearing age: confused terminology, lack of evidence and resulting clinical inertia.
    Br J Dermatol. 2024 Oct 12:ljae398. doi: 10.1093.
    >> Share

  169. LAI C, Fuggle NR, Matin RN, Tanaka RJ, et al
    Artificial Intelligence and Machine Learning in Dermatological Research and Healthcare: British Society for Investigative Dermatology Skin Club Report - Southampton April 2024.
    Br J Dermatol. 2024 Oct 12:ljae395. doi: 10.1093.
    >> Share

  170. VAN DER WEYDEN L, Del Castillo Velasco-Herrera M, Cheema S, Wong K, et al
    Comprehensive mutational profiling identifies new driver events in cutaneous leiomyosarcoma.
    Br J Dermatol. 2024 Oct 11:ljae386. doi: 10.1093.
    >> Share


  171. Correction to: Single-cell RNA sequencing comparison of CD4+, CD8+ and T-cell receptor gammadelta+ cutaneous T-cell lymphomas reveals subset-specific molecular phenotypes.
    Br J Dermatol. 2024 Oct 11:ljae374. doi: 10.1093.
    >> Share

  172. EJEZIE CL, Ayieko S, Anunobi P, Oladoyin J, et al
    Skin Bleaching: A Socio-ecological Perspective.
    Br J Dermatol. 2024 Oct 9:ljae368. doi: 10.1093.
    >> Share

  173. BLAUVELT A, Reckleff J, Zhao Y, Clark M, et al
    Content Evaluation of Pruritus, Skin Pain, and Sleep Disturbance Patient-Reported Outcome Measures in Adolescents and Adults With Moderate-to-Severe Atopic Dermatitis: Qualitative Interviews.
    Br J Dermatol. 2024 Oct 4:ljae346. doi: 10.1093.
    >> Share

  174. KAMMINGA NC, Kievits JE, Plaisier PW, Burgers JS, et al
    Do Large Language Model Chatbots perform better than established patient information resources in answering patient questions? A comparative study on melanoma.
    Br J Dermatol. 2024 Oct 4:ljae377. doi: 10.1093.
    >> Share

  175. ROMANI J, Roses C, Brillet F, Fernandez-Vela J, et al
    Microbiome characterization of skin biopsies in Spanish patients with hidradenitis suppurativa shows a decrease in D1 and H1 lineages of Cutibacterium acnes.
    Br J Dermatol. 2024 Oct 1:ljae371. doi: 10.1093.
    >> Share

  176. PANDEYA N, Olsen CM, Neale RE, Whiteman DC, et al
    Melanoma as a detection-dependent cancer: proxy measures of screening and surveillance associated with 3-year incidence of detection procedures for skin cancer in a national prospective study.
    Br J Dermatol. 2024 Oct 1:ljae372. doi: 10.1093.
    >> Share

    September 2024
  177. LAI CC, Shao SC, Tsai ET, Chi CC, et al
    Efficacy and safety of biologics and small molecule inhibitors in treating genital psoriasis: A systematic review of randomised controlled trials.
    Br J Dermatol. 2024 Sep 30:ljae370. doi: 10.1093.
    >> Share

  178. SOUTH AP
    Stopping a runaway train: targeting fibrosis in recessive dystrophic epidermolysis bullosa.
    Br J Dermatol. 2024;191:482-483.
    >> Share

  179. CHEN ML, Kim J, Naik HB, Aleshin MA, et al
    Analysing common topics of secure patient messages in hidradenitis suppurativa: a text-embedding and natural language-processing approach.
    Br J Dermatol. 2024;191:633-635.
    >> Share

  180. CARRASCOSA JM, Munera-Campos M
    Prurigo nodularis: the difference between knowing the path and walking the path.
    Br J Dermatol. 2024;191:480-481.
    >> Share

  181. KIM J, Kim JH
    Clinical relevance of circulating autoantigen-specific T-follicular regulatory cells in pemphigus vulgaris.
    Br J Dermatol. 2024;191:485-486.
    >> Share

  182. BERTOLD C, Delaunay P, Cathelineau AC, Chassang M, et al
    Efficacy of hypnotherapy in chronic idiopathic pruritus: a single-arm prospective pilot study.
    Br J Dermatol. 2024;191:644-645.
    >> Share

  183. AMBER KT, Feldman RJ
    The safety of topical vs. oral steroids in bullous pemphigoid: considerations for retrospective analyses.
    Br J Dermatol. 2024;191:479-480.
    >> Share

  184. HEBERT V, Novarino J, Maho-Vaillant M, Perals C, et al
    The emergence of circulating activated autoreactive desmoglein 3-specific follicular regulatory T cells is associated with long-term efficacy of rituximab in patients with pemphigus vulgaris.
    Br J Dermatol. 2024;191:605-615.
    >> Share

  185. BAHLOUL D, Hudson R, Balogh O, Mathias E, et al
    Prevalence, incidence and treatment patterns of prurigo nodularis in England: a retrospective database analysis.
    Br J Dermatol. 2024;191:548-555.
    >> Share

  186. BESSIS D, Poujade L, Cossee M, Boursier G, et al
    Mosaic EGFR exon 20 in-frame insertion pathogenic variants are associated with papular epidermal naevus with 'skyline' basal cell layer (PENS).
    Br J Dermatol. 2024;191:641-644.
    >> Share

  187. HUBENTHAL M, Dai C, Brown SJ, Heinrich L, et al
    Mapping SCORing of Atopic Dermatitis (SCORAD) and objective SCORAD to the Eczema Area and Severity Index to facilitate large-scale meta-analyses of molecular data.
    Br J Dermatol. 2024;191:637-639.
    >> Share

  188. PRIMERANO A, De Domenico E, Cianfarani F, De Luca N, et al
    Histone deacetylase inhibition mitigates fibrosis-driven disease progression in recessive dystrophic epidermolysis bullosa.
    Br J Dermatol. 2024;191:568-579.
    >> Share

  189. JOHNS JR, Vyas J, Ali FM, Ingram JR, et al
    The Dermatology Life Quality Index as the primary outcome in randomized clinical trials: a systematic review.
    Br J Dermatol. 2024;191:497-507.
    >> Share

  190. GARATE D, Thang CJ, Schmidt M, Ravanassa S, et al
    Granuloma annulare and the risk of autoimmune conditions: a multicentre retrospective cohort analysis.
    Br J Dermatol. 2024;191:626-627.
    >> Share

  191. KRIDIN K, Bieber K, Vorobyev A, Moderegger EL, et al
    Risk of death, major adverse cardiac events and relapse in patients with bullous pemphigoid treated with systemic or topical corticosteroids.
    Br J Dermatol. 2024;191:539-547.
    >> Share

  192. LYONS D, Louly Nathan A, Pender E, Murray G, et al
    Semaglutide for weight loss in people with obesity as an adjunctive treatment for hidradenitis suppurativa: its impact on disease control and quality of life.
    Br J Dermatol. 2024;191:631-633.
    >> Share

  193. LONG A, O'Malley S, Collins S
    The sunbed trend in Ireland.
    Br J Dermatol. 2024;191:630-631.
    >> Share

  194. ALAVI A, Prens EP, Kimball AB, Frew JW, et al
    Proof-of-concept study exploring the effect of spesolimab in patients with moderate-to-severe hidradenitis suppurativa: a randomized double-blind placebo-controlled clinical trial.
    Br J Dermatol. 2024;191:508-518.
    >> Share

  195. CARR DF, Hanson A
    Stevens-Johnson syndrome/toxic epidermal necrolysis: international consensus, advances and opportunities.
    Br J Dermatol. 2024 Sep 16:ljae358. doi: 10.1093.
    >> Share

  196. TENSEN CP, Vermeer MH
    Single cell analyses of cutaneous T-cell lymphoma biopsies.
    Br J Dermatol. 2024 Sep 13:ljae351. doi: 10.1093.
    >> Share

  197. GALENTINE E, Powers CM, McAleer L, Rivera S, et al
    Hidden hurts: life with lichen sclerosus - a patient perspective.
    Br J Dermatol. 2024 Sep 12:ljae357. doi: 10.1093.
    >> Share

  198. STEVENS HP, Pampena R, Farnetani F, Pellicani G, et al
    The use of Reflectance Confocal Microscopy to diagnose Basal Cell Carcinoma in the United Kingdom: A Prospective Observational Trial at a Single Centre.
    Br J Dermatol. 2024 Sep 11:ljae356. doi: 10.1093.
    >> Share

  199. STEVENS HP, Pellacani G, Angus C, El-Jabbour JN, et al
    The use of Reflectance Confocal Microscopy to diagnose Malignant Melanoma and Lentigo Maligna in the United Kingdom: A Prospective Observational Trial at a Single Centre.
    Br J Dermatol. 2024 Sep 10:ljae354. doi: 10.1093.
    >> Share

  200. HAAG C, Alexis A, Aoki V, Bissonnette R, et al
    A Practical Guide to Using Oral JAK Inhibitors for Atopic Dermatitis from the International Eczema Council.
    Br J Dermatol. 2024 Sep 10:ljae342. doi: 10.1093.
    >> Share

  201. MAHUMUD RA
    The emerging burden of melanoma overdiagnosis in Australia: Who bears the cost-patients or the healthcare system?
    Br J Dermatol. 2024 Sep 9:ljae339. doi: 10.1093.
    >> Share

  202. POSADA V, Toland AE
    Role of albinism and pigment-related genes in amelanotic melanoma formation.
    Br J Dermatol. 2024 Sep 9:ljae353. doi: 10.1093.
    >> Share

  203. SIMPSON C, Leducq S, Venables Z, Yiu ZZN, et al
    The association between prescribed oral anti-diabetic medication for type 2 diabetes mellitus and skin cancer risk: a systematic review and meta-analysis.
    Br J Dermatol. 2024 Sep 6:ljae341. doi: 10.1093.
    >> Share

  204. ARDERN-JONES MR, Brown SJ, Flohr C, Hossain P, et al
    An expert consensus on managing dupilumab-related ocular surface disorders in people with atopic dermatitis 2024.
    Br J Dermatol. 2024 Sep 5:ljae344. doi: 10.1093.
    >> Share

  205. GELLER AC, Stratigos AJ
    Exploring sex and site- specific differences in melanoma.
    Br J Dermatol. 2024 Sep 4:ljae345. doi: 10.1093.
    >> Share

    August 2024
  206. YAMAZAKI E, Fujimura T, Takahashi-Watanabe M, Tada S, et al
    Decreased serum levels of IL-4 correlate with the efficacy of the PAI-1 inhibitor TM5614 in patients with malignant melanoma refractory to anti-PD-1 antibodies: post hoc study of TM5614-MM trial.
    Br J Dermatol. 2024 Aug 31:ljae343. doi: 10.1093.
    >> Share

  207. WEI L, Fitzgerald ME, Yan L, Murakami M, et al
    Photodynamic therapy reduces the burden of small ultraviolet-induced epidermal clones in human and mouse skin.
    Br J Dermatol. 2024 Aug 27:ljae314. doi: 10.1093.
    >> Share

  208. AHMED A, Mohandas P, Taylor R, Assalman I, et al
    'Psycholag': a new term to describe the delay between physical and psychological improvement in patients with skin disease.
    Br J Dermatol. 2024 Aug 22:ljae333. doi: 10.1093.
    >> Share

  209. GIPPLE MO, Dhami RK, Latour E, Keller JJ, et al
    Morgellons disease shows a lower quality of life than psoriasis, atopic dermatitis, and prurigo nodularis.
    Br J Dermatol. 2024 Aug 21:ljae335. doi: 10.1093.
    >> Share

  210. STURM RA, Smit DJ, Duffy DL, McLean C, et al
    Uncovering molecular mechanisms for amelanotic/hypopigmented primary cutaneous melanoma.
    Br J Dermatol. 2024 Aug 21:ljae336. doi: 10.1093.
    >> Share

  211. SERVATTALAB SE, Lee M, Hlobik M, Song H, et al
    Examining racial and ethnic disparities in diagnosis and access to care in infantile atopic dermatitis in the United States: a retrospective cohort study.
    Br J Dermatol. 2024 Aug 20:ljae322. doi: 10.1093.
    >> Share

  212. O'REILLY P, Walsh S, Bunker CB, Ryan S, et al
    The quality-of-life impact of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) on patients' lives: An interpretative descriptive qualitative study.
    Br J Dermatol. 2024 Aug 20:ljae334. doi: 10.1093.
    >> Share

  213. KPENOU FC, Paul C, Seneschal J, Andreu N, et al
    The Atopic Dermatitis Patient Journey: Insights from a Qualitative Study.
    Br J Dermatol. 2024 Aug 18:ljae329. doi: 10.1093.
    >> Share

  214. CHIESA FUXENCH ZC, Mitra N, Grice E, Hoffstad O, et al
    Is seborrhoeic dermatitis of infancy and childhood related to maternal history of seborrhoeic dermatitis? A large population-based cohort study from the UK.
    Br J Dermatol. 2024 Aug 18:ljae331. doi: 10.1093.
    >> Share

  215. KORTE EWH, Pasmooij AMG, Bolling MC, Hickey S, et al
    Towards a roadmap for COSEB: the next steps in harmonization of outcomes for epidermolysis bullosa.
    Br J Dermatol. 2024;191:463-465.
    >> Share

  216. OH BH, Kim KH
    Applying a novel optical technique for residual cancer detection with accuracy evaluation: a cornerstone for field implementation.
    Br J Dermatol. 2024;191:322-323.
    >> Share

  217. EHIZOGIE E, Maghari I, Lo S, Albrecht J, et al
    Hidradenitis suppurativa, systemic inflammatory response syndrome and sepsis: a database study.
    Br J Dermatol. 2024;191:451-453.
    >> Share

  218. CURMAN P, Jebril W, Larsson H, Bachar-Wikstrom E, et al
    Increased risk of depression and anxiety in individuals with Darier disease.
    Br J Dermatol. 2024;191:462-463.
    >> Share

  219. YIU D, Aguilar-Duran S, Edwards C, Chauhan D, et al
    Increased incidence of co-trimoxazole-induced rash in patients on systemic corticosteroid treatment for toxicity associated with immune checkpoint inhibitors.
    Br J Dermatol. 2024;191:465-467.
    >> Share

  220. DALE C, Hewitt RM, Purcell C, Pandya N, et al
    'Feeling like a second-class citizen': exploring the impact, self-management and existing support for adults living with acne and/or post-inflammatory hyperpigmentation and scarring.
    Br J Dermatol. 2024;191:469-470.
    >> Share

  221. HAS C
    MiTES: itch or pain?
    Br J Dermatol. 2024;191:323-324.
    >> Share

  222. RHODES LE
    Vitamin D status in patients with erythropoietic protoporphyria taking the systemic photoprotective agent afamelanotide.
    Br J Dermatol. 2024;191:317-318.
    >> Share

  223. STADLER R
    The interferon story continues: EORTC CLTG study explores pegylated interferon alpha-2a's role in treating mycosis fungoides/Sezary syndrome.
    Br J Dermatol. 2024;191:321-322.
    >> Share

  224. DEKKERS C, de Bruin-Weller M
    The pleiotropic role of interleukin-13 in the pathogenesis of atopic dermatitis.
    Br J Dermatol. 2024;191:316-317.
    >> Share

  225. MAGHARI I, Abiad H, Griffin T, Albrecht J, et al
    Hidradenitis suppurativa (HS), systemic inflammatory response syndrome and sepsis, sepsis caused by HS: an empty systematic review.
    Br J Dermatol. 2024;191:449-450.
    >> Share

  226. KLUIJVER LG, Nekouei Shahraki M, Wagenmakers MAEM, Hanssen BE, et al
    The effects of cholecalciferol and afamelanotide on vitamin D levels in erythropoietic protoporphyria: a multicentre cohort study.
    Br J Dermatol. 2024;191:357-364.
    >> Share

  227. MITSUNAGA K, Bagot M, Ram-Wolff C, Guenova E, et al
    Real-world study of pegylated interferon alpha-2a to treat mycosis fungoides/Sezary syndrome using time to next treatment as a measure of clinical benefit: an EORTC CLTG study.
    Br J Dermatol. 2024;191:419-427.
    >> Share

  228. COHN E, Palma G, Mastacouris N, Strunk A, et al
    Incidence of anxiety disorder in adults with hidradenitis suppurativa.
    Br J Dermatol. 2024;191:351-356.
    >> Share

  229. NOCHAIWONG S, Ruengorn C, Thavorn K, Noppakun K, et al
    Psychometric evaluation of the multidimensional Uraemic Pruritus in Dialysis patients (UP-Dial) scale: comparison of haemodialysis and peritoneal dialysis patients with chronic pruritus.
    Br J Dermatol. 2024;191:375-384.
    >> Share

  230. SIBBALD C, Castelo-Soccio L
    Review of global epidemiology data for alopecia areata highlights gaps and a call for action.
    Br J Dermatol. 2024;191:315-316.
    >> Share

  231. JEON JJ, Jung SW, Kim YH, Parisi R, et al
    Global, regional and national epidemiology of alopecia areata: a systematic review and modelling study.
    Br J Dermatol. 2024;191:325-335.
    >> Share

  232. BANERJEE A, Ezzedine K, Shore R, Peeva E, et al
    An analysis of inter- and intra-rater Facial Vitiligo Area Scoring Index assessments in adults with active nonsegmental vitiligo.
    Br J Dermatol. 2024;191:453-454.
    >> Share

  233. HAMA N, Aoki S, Chen CB, Hasegawa A, et al
    Recent progress of Stevens-Johnson syndrome/toxic epidermal necrolysis: Diagnosis criteria, pathogenesis and therapy.
    Br J Dermatol. 2024 Aug 14:ljae321. doi: 10.1093.
    >> Share

  234. CHENNAREDDY S, Rindler K, Ruggiero JR, Alkon N, et al
    Single-cell RNA sequencing comparison of CD4+, CD8+ and TCR-gammadelta+ cutaneous T-cell lymphomas reveals subset-specific molecular phenotypes.
    Br J Dermatol. 2024 Aug 12:ljae313. doi: 10.1093.
    >> Share

  235. KIM SR, Choi YG, Jo SJ
    Duration of smoking cessation for the prevention of psoriasis vulgaris and palmoplantar pustulosis.
    Br J Dermatol. 2024 Aug 6:ljae317. doi: 10.1093.
    >> Share

  236. FANG Y, Qi J, Jiang Y, Lin Z, et al
    Fish oil supplementation protects skin from yellowness induced by fine particulate matter through anti-inflammatory mechanism: a randomized, double-blind, placebo-controlled clinical trial.
    Br J Dermatol. 2024 Aug 5:ljae311. doi: 10.1093.
    >> Share

    July 2024
  237. RAYMUNDO C, Cella D, Wagner L, Hippe DS, et al
    Development and psychometric properties of the Functional Assessment of Cancer Therapy-Cutaneous T-Cell Lymphoma (FACT-CTCL).
    Br J Dermatol. 2024 Jul 30:ljae308. doi: 10.1093.
    >> Share

  238. WILLEMZE R
    Primary cutaneous acral CD8+ T-cell lymphoproliferative disorder: a benign or malignant process?
    Br J Dermatol. 2024 Jul 26:ljae303. doi: 10.1093.
    >> Share

  239. DE BRITO M, O'Toole EA
    Exploring the role of cytokeratin-17 in skin tumourigenesis and HPV persistence.
    Br J Dermatol. 2024 Jul 25:ljae294. doi: 10.1093.
    >> Share

  240. ALEXANDER H, Malek R, Prieto-Merino D, Gribaleva E, et al
    A prospective observational cohort study comparing the treatment effectiveness and safety of ciclosporin, dupilumab and methotrexate in adult and paediatric patients with atopic dermatitis: results from the UK-Irish A-STAR register.
    Br J Dermatol. 2024 Jul 24:ljae287. doi: 10.1093.
    >> Share

  241. VAN DOORN R
    Supplemental vitamin D on trial: no evidence of benefit as an adjuvant treatment for melanoma.
    Br J Dermatol. 2024 Jul 23:ljae302. doi: 10.1093.
    >> Share

  242. LINDSAY D, Bell KJL, Olsen CM, Whiteman DC, et al
    Estimating the magnitude and healthcare costs of melanoma in situ and thin invasive melanoma overdiagnosis in Australia.
    Br J Dermatol. 2024 Jul 19:ljae296. doi: 10.1093.
    >> Share

  243. OLSEN CM, Pandeya N, Neale RE, Law MH, et al
    Phenotypic and genotypic risk factors for invasive melanoma by sex and body site.
    Br J Dermatol. 2024 Jul 19:ljae297. doi: 10.1093.
    >> Share

  244. HARRISON SR, Campbell F, Bennett H, De Marco G, et al
    High prevalence of undiagnosed and undertreated psoriasis in a UK urban population: results from the observational COPPACA study.
    Br J Dermatol. 2024 Jul 19:ljae292. doi: 10.1093.
    >> Share

  245. RENTROIA-PACHECO B, Shain AH
    Cutaneous squamous cell carcinoma progression: what does a meta-analysis of transcriptomic studies tell us?
    Br J Dermatol. 2024 Jul 17:ljae293. doi: 10.1093.
    >> Share

  246. MACAULAY ARK, Yang J, Price MA, Forster CL, et al
    Chondroitin sulfate proteoglycan 4 (CSPG4) increases invasion of recessive dystrophic epidermolysis bullosa-associated cutaneous squamous cell carcinoma by modifying TGFbeta signaling.
    Br J Dermatol. 2024 Jul 17:ljae295. doi: 10.1093.
    >> Share


  247. Correction to: Prevalence, incidence, mortality and healthcare resource use for generalized pustular psoriasis, palmoplantar pustulosis and plaque psoriasis in England: a population-based cohort study.
    Br J Dermatol. 2024 Jul 17:ljae285. doi: 10.1093.
    >> Share


  248. New British Skin Foundation/Skin Health Alliance Psychodermatology Research Award now available.
    Br J Dermatol. 2024;191:309.
    >> Share

  249. BATTISTELLA M
    Paediatric lymphomatoid papulosis: a benign clonal T-cell disorder that is a harbinger of haematological malignancy.
    Br J Dermatol. 2024;191:158-159.
    >> Share

  250. DOOLAN BJ, Thomas BR
    Bursting the bubble on diagnostics: artificial intelligence in autoimmune bullous disease.
    Br J Dermatol. 2024;191:160-161.
    >> Share

  251. ANDRADE LF, Haq Z, Abdi P, Diaz MJ, et al
    Impact of pruritus on patient fatigue: a cross-sectional study.
    Br J Dermatol. 2024;191:292-293.
    >> Share

  252. REICH A
    Nemolizumab: a new key player in the treatment of prurigo nodularis.
    Br J Dermatol. 2024;191:154-155.
    >> Share

  253. THEIN D, Maul JT, Schmid-Grendelmeier P, Thyssen JP, et al
    Prevalence of ichthyoses in Denmark: a nationwide registry-based study.
    Br J Dermatol. 2024;191:305-306.
    >> Share

  254. SAMUELOV L
    Dystrophic epidermolysis bullosa: from disease biology to biologic therapy.
    Br J Dermatol. 2024;191:159-160.
    >> Share

  255. GAMBICHLER T, Razeghpour F, Sorescu E, Stucker M, et al
    High intratumoral 5-hydroxymethylcytosine levels protect against disease relapse in patients with atypical fibroxanthoma and pleomorphic dermal sarcoma.
    Br J Dermatol. 2024;191:295-296.
    >> Share

  256. GUPTA V, Taneja N, Sati HC, Sreenivas V, et al
    'Substantial clinical benefit' and 'substantial clinical worsening' cutoff of Vitiligo Impact Scale (VIS)-22 change scores.
    Br J Dermatol. 2024;191:307-308.
    >> Share

  257. GRATTAN CEH, Kocaturk E
    How relevant are eosinophils to chronic spontaneous urticaria? No evidence of clinical benefit from eosinophil depletion with benralizumab.
    Br J Dermatol. 2024;191:153-154.
    >> Share

  258. SARKOVICS K, Kolodney JA, Kolodney MS
    Programmed death receptor-1 and programmed death ligand-1 checkpoint inhibition-associated bullous pemphigoid: a propensity-matched retrospective cohort study.
    Br J Dermatol. 2024;191:299-300.
    >> Share

  259. YOKOZEKI H, Murota H, Matsumura T, Komazaki H, et al
    Efficacy and safety of nemolizumab and topical corticosteroids for prurigo nodularis: results from a randomized double-blind placebo-controlled phase II/III clinical study in patients aged >/= 13 years.
    Br J Dermatol. 2024;191:200-208.
    >> Share

  260. BRAZZELLI V, Michelerio A
    Use of a large patient database to analyse disease burden and treatment patterns among patients with vitiligo.
    Br J Dermatol. 2024;191:156-157.
    >> Share

  261. MCCARTHY RL, Schwartz J, Oldham J, Bodemer C, et al
    A cross-sectional study of erythromelalgia in patients with pachyonychia congenita.
    Br J Dermatol. 2024;191:300-302.
    >> Share

  262. CAPURRO N, Pastore VP, Touijer L, Odone F, et al
    A deep learning approach to direct immunofluorescence pattern recognition in autoimmune bullous diseases.
    Br J Dermatol. 2024;191:261-266.
    >> Share

  263. ELEFTHERIADOU V, Delattre C, Chetty-Mhlanga S, Lee C, et al
    Burden of disease and treatment patterns in patients with vitiligo: findings from a national longitudinal retrospective study in the UK.
    Br J Dermatol. 2024;191:216-224.
    >> Share

  264. LAIMER M
    Nonsense variant readthrough therapy for epidermolysis bullosa.
    Br J Dermatol. 2024;191:161-162.
    >> Share

  265. CAMPBELL F, Laws P
    Managing risk of liver fibrosis in patients with psoriasis being considered for methotrexate.
    Br J Dermatol. 2024;191:163.
    >> Share

  266. ALTRICHTER S, Gimenez-Arnau AM, Bernstein JA, Metz M, et al
    Benralizumab does not elicit therapeutic effect in patients with chronic spontaneous urticaria: results from the phase IIb multinational randomized double-blind placebo-controlled ARROYO trial.
    Br J Dermatol. 2024;191:187-199.
    >> Share

  267. WOODLEY DT, Hao M, Kwong A, Levian B, et al
    Intravenous gentamicin therapy induces functional type VII collagen in patients with recessive dystrophic epidermolysis bullosa: an open-label clinical trial.
    Br J Dermatol. 2024;191:267-274.
    >> Share

  268. HOWELLS L
    Patient-Reported Impact of Dermatological Diseases (PRIDD) is a new patient-reported outcome measure for dermatology: why is it needed?
    Br J Dermatol. 2024;191:e4.
    >> Share

  269. XU Y, Guo L, Wu S, Zhang T, et al
    Causal effect of elevated body mass index on hidradenitis suppurativa: a two-sample Mendelian randomization study.
    Br J Dermatol. 2024;191:290-292.
    >> Share

  270. HUANG Y, Pu W, Wang L, Ma Q, et al
    ACKR1+ Endothelial Cells Mediate Leukocyte Infiltration and Synergize with SFRP2/ASPN+ Fibroblasts to Promote Skin Fibrosis in Systemic Sclerosis.
    Br J Dermatol. 2024 Jul 15:ljae286. doi: 10.1093.
    >> Share

  271. BRUCE G, Rosala-Hallas A, Jones AP, Turner C, et al
    The effects of ciclosporin and methotrexate on kidney function in the treatment of severe atopic dermatitis in children - results from the TREAT trial.
    Br J Dermatol. 2024 Jul 15:ljae276. doi: 10.1093.
    >> Share

  272. WANG H, Wu Y, Bassetti JA, Wang Z, et al
    A gain-of-function variant in SREBF1 causes generalized skin hyperpigmentation with congenital cataracts.
    Br J Dermatol. 2024 Jul 15:ljae291. doi: 10.1093.
    >> Share

  273. LI A, Musters AH, Hyseni A, Gerbens LAA, et al
    Dupilumab-associated (hyper)eosinophilia in patients with atopic dermatitis: a single-center cohort study of the TREAT NL (TREatment of ATopic eczema, the Netherlands) registry.
    Br J Dermatol. 2024 Jul 15:ljae289. doi: 10.1093.
    >> Share

  274. LALLAS K, Spyridonos P, Kittler H, Tschandl P, et al
    Prediction of melanoma metastasis using dermatoscopy deep features. An international multicenter cohort study.
    Br J Dermatol. 2024 Jul 12:ljae281. doi: 10.1093.
    >> Share

  275. DAVITI M, Papadimitriou I, Cinotti E, Lallas A, et al
    Atypical melanocytes of an Atypical Spitz Tumor observed with Optical Super-High Magnification Dermoscopy.
    Br J Dermatol. 2024 Jul 2:ljae277. doi: 10.1093.
    >> Share

  276. JIA Q, Cao Q, Peng C, Shui X, et al
    Predictive features for effectiveness of dupilumab in elderly patients with atopic dermatitis: a real-world study.
    Br J Dermatol. 2024 Jul 2:ljae278. doi: 10.1093.
    >> Share

  277. KLEEMANN J, Schilling B
    Multicenter phase II trial of plasminogen activator inhibitor-1 inhibitor (TM5614) plus nivolumab in japanese advanced melanoma patients: Immune resistance remains one of the major efforts in melanoma research.
    Br J Dermatol. 2024 Jul 2:ljae279. doi: 10.1093.
    >> Share

    June 2024
  278. SCHIELEIN L, Ziehfreund S, Biedermann T, Zink A, et al
    "When you do not feel comfortable in your skin, you cannot get out of it" - A Qualitative Interview Study exploring Psychosocial Impact and Coping Strategies among Patients with Prurigo Nodularis.
    Br J Dermatol. 2024 Jun 28:ljae274. doi: 10.1093.
    >> Share

  279. WOBSE M, Appenzeller S, Roth S, Siedel C, et al
    Oncogenic alterations in KIR3DL1 in cutaneous acral CD8+ lymphoproliferative disorder.
    Br J Dermatol. 2024 Jun 27:ljae256. doi: 10.1093.
    >> Share

  280. HAGENSTROM K, Klinger T, Muller K, Willers C, et al
    Utilization and related harms of systemic glucocorticosteroids for atopic dermatitis: claims data analysis.
    Br J Dermatol. 2024 Jun 27:ljae250. doi: 10.1093.
    >> Share

  281. VON KOBYLETZKI LB, Svensson A
    Generalised pustular psoriasis, palmoplantar pustulosis, and plaque psoriasis have different survival rates and health care needs.
    Br J Dermatol. 2024 Jun 25:ljae271. doi: 10.1093.
    >> Share

  282. ESPOSITO M, Yerly L, Shukla P, Hermes V, et al
    COL10A1 expression distinguishes a subset of cancer-associated fibroblasts present in the stroma of high-risk basal cell carcinoma.
    Br J Dermatol. 2024 Jun 25:ljae258. doi: 10.1093.
    >> Share

  283. DE SMEDT J, Van Kelst S, Janssen L, Marasigan V, et al
    High dose vitamin D supplementation does not improve outcome in a cutaneous melanoma population: results of a randomized double-blind, placebo-controlled study (ViDMe trial).
    Br J Dermatol. 2024 Jun 24:ljae257. doi: 10.1093.
    >> Share


  284. Long-term response to treatment with guselkumab in people with moderate-to-severe psoriasis.
    Br J Dermatol. 2024;191:e3.
    >> Share

  285. TZOUMPA S, Ingen-Housz-Oro S, de Masson A, Pham-Ledard A, et al
    Evolution of patients with Sezary syndrome after mogamulizumab discontinuation for any cause except progression: a multicentre retrospective study (Moga-stop Study).
    Br J Dermatol. 2024;191:143-144.
    >> Share

  286. XIE W, Kong X, Liu W, Liang G, et al
    Antifungal-resistant Trichophyton indotineae: transmission warrants priority attention and international collaboration.
    Br J Dermatol. 2024;191:146-147.
    >> Share

  287. HORISSIAN M, Samaan C, Cohrs A, Kirby J, et al
    Trends in antibiotic prescriptions for hidradenitis suppurativa from 2015 to 2021.
    Br J Dermatol. 2024;191:142-143.
    >> Share

  288. ABDOLRASOULI A, Hay RJ
    Antifungal-resistant Trichophyton indotineae: transmission is occurring outside previously identified endemic areas - are we prepared?
    Br J Dermatol. 2024;191:145-146.
    >> Share

  289. DANBY SG
    Debunking the myth that all emollients are equal opens the door for future atopic dermatitis prevention studies.
    Br J Dermatol. 2024;191:6-7.
    >> Share

  290. TULL TJ, Benton EC, Semkova K, Watson NA, et al
    Combined rituximab and belimumab to treat recalcitrant epidermolysis bullosa aquisita associated with systemic lupus erythematosus.
    Br J Dermatol. 2024;191:138-140.
    >> Share

  291. GOLETZ S, Probst C, Komorowski L, Radzimski C, et al
    Sensitive and specific assay for the serological diagnosis of anti-p200 pemphigoid based on the recombinant laminin beta4 subunit.
    Br J Dermatol. 2024;191:140-141.
    >> Share

  292. LIU Y, Liu J, Chen Y, Mo R, et al
    Potential digenic inheritance of SERPINB7 and SERPINA12 variants in Chinese patients with Nagashima-type palmoplantar keratosis.
    Br J Dermatol. 2024;191:136-138.
    >> Share

  293. LIANG L, Peng S, Huang S, Wang H, et al
    Progressive hyperpigmentation and lentigines due to KIT variants improving with imatinib.
    Br J Dermatol. 2024;191:148-149.
    >> Share

  294. KEARNEY N, Kirby B
    Prior exposure to fumaric acid esters does not impact on subsequent treatment response to guselkumab.
    Br J Dermatol. 2024;191:5-6.
    >> Share

  295. SALAMON G, Strobl S, Field-Werners U, Diem A, et al
    Psychometric Properties of the Instrument for Scoring Clinical Outcomes of Research for Epidermolysis Bullosa patient score (iscorEB-p): a patient-reported outcome measure.
    Br J Dermatol. 2024;191:75-81.
    >> Share

  296. THACI D, Pinter A, Sebastian M, Termeer C, et al
    Guselkumab demonstrates long-term efficacy and maintenance of treatment response postwithdrawal in systemic treatment-naive patients and nonresponders to fumaric acid esters: results from parts II and III of a randomized active-comparator-controlled p
    Br J Dermatol. 2024;191:36-48.
    >> Share

  297. HASCHE D, Hufbauer M, Braspenning-Wesch I, Stephan S, et al
    Cytokeratin-17 expression is commonly observed in keratinocytic skin tumours and controls tissue homeostasis impacting HPV protein expression.
    Br J Dermatol. 2024 Jun 15:ljae255. doi: 10.1093.
    >> Share

  298. MCMAHON M, Deacon DC
    Spatial sequencing reveals transcriptional variation between amelanotic and pigmented acral melanoma.
    Br J Dermatol. 2024 Jun 15:ljae253. doi: 10.1093.
    >> Share

  299. FISCHER G
    The impact of vulval lichen sclerosus in young people: a call for better awareness, individualised maintenance plans and revised guidelines.
    Br J Dermatol. 2024 Jun 15:ljae254. doi: 10.1093.
    >> Share

  300. BENCOMO T, Lee CS
    Gene expression landscape of cutaneous squamous cell carcinoma progression.
    Br J Dermatol. 2024 Jun 13:ljae249. doi: 10.1093.
    >> Share

  301. BARBAROT S, Aubert H, Vibet MA, Leray M, et al
    Effectiveness of a nurse-led one-to-one education programme in addition to standard care in children with atopic dermatitis: a multicentre randomized control trial.
    Br J Dermatol. 2024 Jun 12:ljae111. doi: 10.1093.
    >> Share

  302. FISCHER J
    Confetti Cure: Reversing the Genetic Kaleidoscope of Ichthyosis.
    Br J Dermatol. 2024 Jun 11:ljae248. doi: 10.1093.
    >> Share

  303. MITRA R, Fitzsimmons H, Hale T, Tan ST, et al
    Recent Advances in Understanding the Molecular Basis of Infantile Haemangioma Development.
    Br J Dermatol. 2024 Jun 7:ljae241. doi: 10.1093.
    >> Share

  304. VENABLES ZC, Wakkee M
    Basal cell carcinoma incidence trends - can we stop the surge?
    Br J Dermatol. 2024 Jun 5:ljae239. doi: 10.1093.
    >> Share

  305. LOUVEAU B, Nakouri I, Jouenne F, Baroudjian B, et al
    Genomic profiling of a skin adnexal carcinomas cohort using a comprehensive high throughput sequencing approach.
    Br J Dermatol. 2024 Jun 5:ljae233. doi: 10.1093.
    >> Share

  306. GUTTMAN-YASSKY E, Croft M, Geng B, Rynkiewicz N, et al
    The role of OX40L/OX40 axis signalling in atopic dermatitis.
    Br J Dermatol. 2024 Jun 5:ljae230. doi: 10.1093.
    >> Share

  307. FUJIMURA T, Yoshino K, Kato H, Fukushima S, et al
    Phase II, multicenter study of plasminogen activator inhibitor-1 inhibitor (TM5614) plus nivolumab for treating anti-PD-1 antibody-refractory malignant melanoma: TM5614-MM trial.
    Br J Dermatol. 2024 Jun 4:ljae231. doi: 10.1093.
    >> Share

    May 2024
  308. KISS O, Bahri R, Watson REB, Chike C, et al
    The impact of irritant challenge on the skin barrier and myeloid resident immune cells in post-menopausal women is modulated by hormone replacement therapy.
    Br J Dermatol. 2024 May 31:ljae226. doi: 10.1093.
    >> Share

  309. CHOI ME, Choi EJ, Lee JH, Won CH, et al
    Spatial transcriptome analysis of amelanotic acral melanoma reveals distant molecular determinants compared to pigmented acral melanoma.
    Br J Dermatol. 2024 May 30:ljae224. doi: 10.1093.
    >> Share

  310. SHEN CH, Yang YS, Lee IT, Chiang MH, et al
    Sodium-glucose cotransporter protein-2 inhibitors for diabetes and the reduced risk of inflammatory skin diseases.
    Br J Dermatol. 2024 May 29:ljae229. doi: 10.1093.
    >> Share

  311. BARBIERI A, Orloff J, Gulati N, Brown RM, et al
    Living in my own skin: dermatological concerns and gender-affirming care as a trans person with neurofibromatosis type 1.
    Br J Dermatol. 2024 May 27:ljae170. doi: 10.1093.
    >> Share

  312. VAHER H
    Expanding the knowledge about the TNF-alpha induced GSDME-mediated pyroptosis in psoriasis.
    Br J Dermatol. 2024 May 23:ljae223. doi: 10.1093.
    >> Share

  313. LUO L, Cheng H, Liu Z, Olszewski P, et al
    Single-cell transcriptomic analysis identifies infiltrating plasmacytoid dendritic cells in psoriasis epidermis.
    Br J Dermatol. 2024 May 22:ljae210. doi: 10.1093.
    >> Share


  314. Correction to: Loss-of-function variants in GLMN are associated with generalized skin hyperpigmentation with or without glomuvenous malformation.
    Br J Dermatol. 2024 May 22:ljae212. doi: 10.1093.
    >> Share

  315. FRYSZ M, Patel S, Li MOY, Griffiths CEM, et al
    Prevalence, incidence, mortality, and healthcare resource use for generalised pustular psoriasis, palmoplantar pustulosis, and plaque psoriasis in England: a population-based cohort study.
    Br J Dermatol. 2024 May 22:ljae217. doi: 10.1093.
    >> Share

  316. HANRAHAN GB, Tsibris HC
    Mutational Landscape and Tumor Mutational Burden in Adult Patients with Malignant Melanoma Arising From Congenital Nevi.
    Br J Dermatol. 2024 May 21:ljae214. doi: 10.1093.
    >> Share

  317. MORREL B, Kampherbeek JHJ, Ten Kate-Booij MJ, van der Avoort IAM, et al
    Growing up with juvenile vulvar lichen sclerosus, the experiences and care needs of adult women with lichen sclerosus since childhood: a qualitative exploration.
    Br J Dermatol. 2024 May 21:ljae203. doi: 10.1093.
    >> Share


  318. Correction to: Breastfeeding decreases the risk of developing psoriasis through to early adulthood.
    Br J Dermatol. 2024 May 20:ljae208. doi: 10.1093.
    >> Share


  319. Contact allergies to dental material.
    Br J Dermatol. 2024;190:e66.
    >> Share


  320. Predicting the likelihood of hidradenitis suppurativa disease progression based on identified risk factors.
    Br J Dermatol. 2024;190:e67.
    >> Share


  321. The impact of atopic dermatitis on children and adolescents.
    Br J Dermatol. 2024;190:e65.
    >> Share


  322. Incidence, mortality and survival in people with Merkel cell carcinoma: a systematic review.
    Br J Dermatol. 2024;190:e64.
    >> Share

  323. PAVLENKO D, Akiyama T
    Cryosim-1: a cool solution for acute and chronic itch.
    Br J Dermatol. 2024;190:787.
    >> Share

  324. THANG CJ, Garate D, O'Leary S, Golovko G, et al
    Evaluation of the association between tetracycline-class antibiotic use in patients with acne and idiopathic intracranial hypertension risk: a population-level cohort study.
    Br J Dermatol. 2024;190:921-923.
    >> Share

  325. JAMES M, Nakamura M, Whittaker S, Morris S, et al
    Mycosis fungoides: successful re-treatment with brentuximab vedotin.
    Br J Dermatol. 2024;190:929-930.
    >> Share

  326. ZOUBOULIS CC, Passeron T, Pariser D, Wozniak MB, et al
    Secukinumab in patients with moderate-to-severe hidradenitis suppurativa based on prior biologic exposure: an efficacy and safety analysis from the SUNSHINE and SUNRISE phase III trials.
    Br J Dermatol. 2024;190:836-845.
    >> Share

  327. KIM DY
    Mortality landscape of Behcet disease.
    Br J Dermatol. 2024;190:784.
    >> Share

  328. BAHAR F, DeCaprio JA
    Why do we distinguish between virus-positive and virus-negative Merkel cell carcinoma?
    Br J Dermatol. 2024;190:785-786.
    >> Share

  329. LIAO V, Cornman HL, Ma E, Kwatra SG, et al
    Prurigo nodularis: new insights into pathogenesis and novel therapeutics.
    Br J Dermatol. 2024;190:798-810.
    >> Share

  330. LEE S, Wei ET, Selescu T, Babes A, et al
    Histamine- and pruritogen-induced itch is inhibited by a TRPM8 agonist: a randomized vehicle-controlled human trial.
    Br J Dermatol. 2024;190:885-894.
    >> Share

  331. GORDON ER, Trager MH, Kontos D, Weng C, et al
    Ethical considerations for artificial intelligence in dermatology: a scoping review.
    Br J Dermatol. 2024;190:789-797.
    >> Share

  332. CHOI SR, Shin A, Ha YJ, Lee YJ, et al
    All-cause and cause-specific mortality in patients with Behcet disease versus the general population.
    Br J Dermatol. 2024;190:858-866.
    >> Share

  333. JOHNSON O
    Living with nodular prurigo.
    Br J Dermatol. 2024;190:915.
    >> Share

  334. GREKOWITZ E, Metz M, Altrichter S, Bauer A, et al
    Targeting histamine receptor 4 in cholinergic urticaria with izuforant (LEO 152020): results from a phase IIa randomized double-blind placebo-controlled multicentre crossover trial.
    Br J Dermatol. 2024;190:825-835.
    >> Share

  335. MARONESE CA, Marzano AV
    Identifying candidates for early intervention in hidradenitis suppurativa.
    Br J Dermatol. 2024;190:787-788.
    >> Share

  336. RAGAMIN A, Zhang J, Pasmans SGMA, Schappin R, et al
    The construct validity, responsiveness, reliability and interpretability of the Recap of atopic eczema questionnaire (RECAP) in children.
    Br J Dermatol. 2024;190:867-875.
    >> Share

  337. TORRE-CASTRO J, Rodriguez M, Alonso-Alonso R, Mendoza Cembranos MD, et al
    LT and SOX9 expression are associated with gene sets that distinguish Merkel cell polyomavirus (MCPyV)-positive and MCPyV-negative Merkel cell carcinoma.
    Br J Dermatol. 2024;190:876-884.
    >> Share

  338. KJAERSGAARD ANDERSEN R, Pedersen O, Eidsmo L, Jemec G, et al
    Initial steps towards developing a predictive algorithm of disease progression for hidradenitis suppurativa (HS): results from a Cox proportional hazard regression analysis on disease progression among a cohort of 335 Danish patients with HS.
    Br J Dermatol. 2024;190:904-914.
    >> Share

  339. CHIESA FUXENCH ZC
    The burden of atopic dermatitis across paediatric populations: 'it's not just an itch that rashes'.
    Br J Dermatol. 2024;190:783-784.
    >> Share

  340. MISTRY K, Venables ZC
    A systematic review of Merkel cell carcinoma epidemiology highlights its rising incidence, poor prognosis and data heterogeneity.
    Br J Dermatol. 2024;190:782-783.
    >> Share

  341. MOHSEN ST, Price EL, Chan AW, Hanna TP, et al
    Incidence, mortality and survival of Merkel cell carcinoma: a systematic review of population-based studies.
    Br J Dermatol. 2024;190:811-824.
    >> Share

  342. OLSEN CM
    Ecological evidence for melanoma overdiagnosis in Denmark.
    Br J Dermatol. 2024 May 16:ljae206. doi: 10.1093.
    >> Share

  343. DU J, Dong C, Lin J, Lu X, et al
    MMP2hi Fibroblasts Regulate CD8+ T Cell Residency and Inflammation via CD100 in Psoriasis.
    Br J Dermatol. 2024 May 16:ljae205. doi: 10.1093.
    >> Share

  344. HAMMAS K, Nardin C, Boyer S, Michel C, et al
    Incidence and trends of first basal cell carcinomas in France between 1980 and 2019: a regional population-based registry study.
    Br J Dermatol. 2024 May 15:ljae201. doi: 10.1093.
    >> Share

  345. TANAHASHI K, Kono M, Yoshikawa T, Suzuki Y, et al
    Treating epidermolytic ichthyosis and ichthyosis with confetti with epidermal autografts cultured from revertant skin.
    Br J Dermatol. 2024 May 13:ljae193. doi: 10.1093.
    >> Share

  346. RODRIGUEZ M, Rebollo-Gonzalez M, Frutos Diaz-Alejo J, Manso R, et al
    Mutational profiling of Primary Cutaneous CD4+ Small/Medium T-Cell Lymphoproliferative Disorders do not resemble nodal peripheral T-cell lymphomas with follicular helper T-cell phenotype.
    Br J Dermatol. 2024 May 13:ljae192. doi: 10.1093.
    >> Share

  347. PARRAGA SP, Feldman SR
    Insulin resistance and psoriasis.
    Br J Dermatol. 2024 May 13:ljae199. doi: 10.1093.
    >> Share

  348. BOITOR RA, Varma S, Sharma A, Odedra S, et al
    Diagnostic accuracy of autofluorescence-Raman spectroscopy for surgical margin assessment during Mohs micrographic surgery of basal cell carcinoma.
    Br J Dermatol. 2024 May 13:ljae196. doi: 10.1093.
    >> Share

  349. PASSERON T, Reinhardt M, Ehst B, Weiss J, et al
    Secukinumab in adult patients with lichen planus: Efficacy and safety results from the randomised, placebo-controlled, proof-of-concept PRELUDE study.
    Br J Dermatol. 2024 May 13:ljae181. doi: 10.1093.
    >> Share

  350. ROBINSON J, Kibbi N, Rajan N
    Redefine "benign": A misnomer in the context of patients with genetic skin tumour syndromes.
    Br J Dermatol. 2024 May 10:ljae185. doi: 10.1093.
    >> Share

  351. GUNTHER C
    IL-17 blockade by secukinumab was not effective in controlling lichen planus in a randomized controlled clinical trial.
    Br J Dermatol. 2024 May 8:ljae186. doi: 10.1093.
    >> Share

  352. ZHANG S, Ran M
    Deceptive Pigment Changes in Neoadjuvant Sonidegib Therapy for Basal Cell Carcinoma.
    Br J Dermatol. 2024 May 4:ljae187. doi: 10.1093.
    >> Share

    April 2024
  353. MALLBRIS MJ, Jia B, Zhao Y, Kahlenberg JM, et al
    Concomitant Moderate to Severe Cutaneous Lesions Have Marked Impact on Quality of Life in Patients with Active Systemic Lupus Erythematosus: A Cross-Sectional Insight from Two Phase 3 Randomised Clinical Trials in Adults.
    Br J Dermatol. 2024 Apr 30:ljae183. doi: 10.1093.
    >> Share

  354. HALIOUA B, Skayem C, Merhand S, Ben Hayoun Y, et al
    Long-term consequences on stigmatization and disease burden during adulthood among patients with childhood or adolescence-onset atopic dermatitis.
    Br J Dermatol. 2024 Apr 29:ljae176. doi: 10.1093.
    >> Share

  355. O'REILLY M, Paolino A, Pathmarajah P, Ferguson J, et al
    Dupilumab in Chronic Actinic Dermatitis: a retrospective case series.
    Br J Dermatol. 2024 Apr 24:ljae180. doi: 10.1093.
    >> Share

  356. LI Y, He Y, Yang F, Liang R, et al
    GSDME-mediated keratinocyte pyroptosis participates in the pathogenesis of psoriasis by promoting skin inflammation.
    Br J Dermatol. 2024 Apr 24:ljae179. doi: 10.1093.
    >> Share

  357. NIELSEN JB, Kristiansen IS, Thapa S
    Increasing melanoma incidence with unchanged mortality: more sunshine, better treatment, increased diagnostic activity, overdiagnosis or lowered diagnostic threshold?
    Br J Dermatol. 2024 Apr 24:ljae175. doi: 10.1093.
    >> Share

  358. LEEOLOU MC, Sarin KY, Fiorentino DF
    Filling the Prescription Gap: The Value of Community Support in Psoriasis Management.
    Br J Dermatol. 2024 Apr 18:ljae168. doi: 10.1093.
    >> Share

  359. HUANG D, Zhong X, Jiang Y, Kong L, et al
    Insulin Resistance Impairs Biological Agents Response in Moderate-to-Severe Plaque Psoriasis: Insights from a Prospective Cohort Study in China.
    Br J Dermatol. 2024 Apr 18:ljae147. doi: 10.1093.
    >> Share


  360. The association between vitamin D levels and psoriasis in people aged 40-79 years.
    Br J Dermatol. 2024;190:e54.
    >> Share


  361. Effectiveness and safety of immunoadsorption in the treatment of pemphigus vulgaris and pemphigus foliaceus.
    Br J Dermatol. 2024;190:e53.
    >> Share


  362. Predictors of response to treatment with biologics in people with moderate-to-severe psoriasis.
    Br J Dermatol. 2024;190:e55.
    >> Share


  363. A novel strategy for the treatment of melanoma.
    Br J Dermatol. 2024;190:e51.
    >> Share


  364. Practical guide for epidermolysis bullosa management in the first 4 weeks of life.
    Br J Dermatol. 2024;190:e52.
    >> Share


  365. The Patient Benefit Index for topical treatment (PBI-TOP): a new questionnaire to assess the treatment goals and preferences of people with psoriasis.
    Br J Dermatol. 2024;190:e56.
    >> Share


  366. Deciding on the final set of questions and groups of questions in the Patient-Reported Impact of Dermatological Diseases (PRIDD) tool.
    Br J Dermatol. 2024;190:e57.
    >> Share


  367. Targeting malignant melanoma cells expressing the protein CD20 enhances BRAF-targeted treatment.
    Br J Dermatol. 2024;190:e58.
    >> Share


  368. UK trends in work-related contact dermatitis caused by nickel, chromium and cobalt.
    Br J Dermatol. 2024;190:e59.
    >> Share


  369. 'Gene creams' for genetic diseases?
    Br J Dermatol. 2024;190:e50.
    >> Share

  370. PASSERON T
    A pledge for a better care and consideration of patients with vitiligo.
    Br J Dermatol. 2024;190:614-615.
    >> Share

  371. SAMPOGNA F, Piaserico S
    Deucravacitinib: is there still a place or a need for a new oral agent?
    Br J Dermatol. 2024;190:610-611.
    >> Share

  372. HASAN SB, Bates J, Cannings-John R, Collier F, et al
    Feasibility of daily pain measurement using text messages in hidradenitis suppurativa clinical trials; data from the THESEUS study.
    Br J Dermatol. 2024;190:775-777.
    >> Share

  373. KYUNG S, Woo S, Kim M, Lee H, et al
    Global burden of vaccine-associated alopecia, 1979-2023: a comprehensive analysis of the international pharmacovigilance database.
    Br J Dermatol. 2024;190:764-767.
    >> Share

  374. MOSS C
    Caring for babies born with epidermolysis bullosa.
    Br J Dermatol. 2024;190:608.
    >> Share

  375. RING HC, Thorsen J, Kirby B, Ingram JR, et al
    Long-term drug survival of adalimumab, infliximab, secukinumab and ustekinumab in hidradenitis suppurativa: a Danish nationwide cohort study.
    Br J Dermatol. 2024;190:769-771.
    >> Share

  376. FAKIH A, Tannous R, Lajnef M, Seneschal J, et al
    Stigma in vitiligo: associated factors and severity strata of the Patient Unique Stigmatization Holistic tool in Dermatology (PUSH-D) score.
    Br J Dermatol. 2024;190:712-717.
    >> Share

  377. HASHIMOTO T, Yamagami J
    Development of a novel treatment for pemphigus and confirmation of its efficacy: a randomized controlled trial of protein A immunoadsorption therapy.
    Br J Dermatol. 2024;190:609.
    >> Share

  378. RIVERA S, Dehner K, Flood A, Dykstra C, et al
    Adverse healthcare experiences are correlated with increased time to diagnosis in women with vulvar inflammatory dermatoses: a retrospective cohort survey.
    Br J Dermatol. 2024;190:761-762.
    >> Share

  379. VAN BEEK N, Eming R, Reuss A, Zillikens D, et al
    Efficacy and safety of adjuvant immunoadsorption in pemphigus vulgaris and pemphigus foliaceus (IA-Pem Study): a multicentre randomized controlled trial.
    Br J Dermatol. 2024;190:657-667.
    >> Share


  380. The 2024 British Skin Foundation Research Awards are now available.
    Br J Dermatol. 2024;190:778.
    >> Share

  381. CHAIYABUTR C, Dawe R, Lesar A, Ibbotson SH, et al
    A retrospective comparison of early- and late-onset chronic actinic dermatitis: characteristics and management.
    Br J Dermatol. 2024 Apr 16:ljae101. doi: 10.1093.
    >> Share

  382. NASLUND-KOCH C, Skov L
    Shedding light on the smoke: Unraveling the impact of smoking cessation on psoriasis development.
    Br J Dermatol. 2024 Apr 15:ljae163. doi: 10.1093.
    >> Share

  383. PHILLIPS C, Russell E, McNiven A, McPherson T, et al
    A Qualitative Study of the Psychological Morbidity in Paediatric Survivors of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
    Br J Dermatol. 2024 Apr 12:ljae154. doi: 10.1093.
    >> Share

  384. BLANCHARD M, Morren MA, Busschots AM, Hauben E, et al
    Paediatric onset lymphomatoid papulosis: results of a multicentre retrospective cohort study, on behalf of the EORTC Cutaneous Lymphoma Tumours Group (CLTG).
    Br J Dermatol. 2024 Apr 10:ljae150. doi: 10.1093.
    >> Share

  385. SIMPSON EL, Eckert L, Gadkari A, Brown TM, et al
    Evaluating the clinical utility of the Atopic Dermatitis Control Tool: measurement properties and agreement between patients' responses and clinicians' impressions of atopic dermatitis control.
    Br J Dermatol. 2024 Apr 9:ljae056. doi: 10.1093.
    >> Share

  386. JONES OT, Matin RN, Walter FM
    Using artificial intelligence-based technologies to support the diagnosis and early detection of melanoma in primary care.
    Br J Dermatol. 2024 Apr 9:ljae094. doi: 10.1093.
    >> Share

  387. CAO Q, Li M
    GLMN variants cause skin hyperpigmentation: a promising potential therapeutic target.
    Br J Dermatol. 2024 Apr 8:ljae149. doi: 10.1093.
    >> Share

  388. ROCCUZZO G, Calvao J, Dobos G, Morsia E, et al
    Cutaneous T-cell lymphoma care across Europe: insights from the Horizon Project.
    Br J Dermatol. 2024 Apr 5:ljae145. doi: 10.1093.
    >> Share

    March 2024
  389. KIM SR, Choi YG, Jo SJ
    Effect of smoking cessation on psoriasis vulgaris, palmoplantar pustulosis, and generalized pustular psoriasis.
    Br J Dermatol. 2024 Mar 27:ljae130. doi: 10.1093.
    >> Share

  390. SANDER N, Stolzl D, Fonfara M, Hartmann J, et al
    Blockade of IL-13 signaling improves skin barrier function and biology in patients with moderate to severe atopic dermatitis.
    Br J Dermatol. 2024 Mar 26:ljae138. doi: 10.1093.
    >> Share

  391. BENTZ P, Weisshaar E
    Biomarkers as key concepts in managing atopic dermatitis and psoriasis: Unlocking new ways of care for patient suffering from chronic hand dermatoses.
    Br J Dermatol. 2024 Mar 26:ljae127. doi: 10.1093.
    >> Share

  392. JOHNSON C, Liao W
    Food for thought: A comment on 'Breast-feeding decreases the risk of developing psoriasis through early adulthood'.
    Br J Dermatol. 2024 Mar 26:ljae135. doi: 10.1093.
    >> Share

  393. SOROKIN AV, Gelfand JM
    New Prospective Cohort Study and Mendelian Randomization Analysis Reveals a Link Between Psoriasis and Cardiovascular Risk Trough Elevated Plasma Triglycerides.
    Br J Dermatol. 2024 Mar 22:ljae129. doi: 10.1093.
    >> Share

  394. TALTY R, Richmond R, Micevic G
    Melanoma TIL therapy commences era of cell-based immunotherapies.
    Br J Dermatol. 2024 Mar 22:ljae126. doi: 10.1093.
    >> Share


  395. Correction to: Circulating biomarkers are associated with disease severity of chronic hand eczema and atopic dermatitis.
    Br J Dermatol. 2024 Mar 22:ljae112. doi: 10.1093.
    >> Share

  396. STRANDMOE AL, Bremer J, Diercks GFH, Gostynski A, et al
    Beyond The Skin: B Cells in Pemphigus Vulgaris, Tolerance and Treatment.
    Br J Dermatol. 2024 Mar 20:ljae107. doi: 10.1093.
    >> Share

  397. JIANG X, Yang C, Wang Z, Liang L, et al
    Loss-of-function variants in GLMN are associated with generalized skin hyperpigmentation with or without glomuvenous malformation.
    Br J Dermatol. 2024 Mar 15:ljae108. doi: 10.1093.
    >> Share


  398. AMBRA1 and loricrin as a test to identify low-risk early-stage melanoma.
    Br J Dermatol. 2024;190:e46.
    >> Share


  399. Blood monitoring during psoriasis treatment with biologics.
    Br J Dermatol. 2024;190:e47.
    >> Share


  400. Safety of bimekizumab over 3 years in patients with psoriasis.
    Br J Dermatol. 2024;190:e38.
    >> Share


  401. International trends in the incidence of cutaneous squamous cell carcinoma and melanoma.
    Br J Dermatol. 2024;190:e40.
    >> Share


  402. Skin barrier dysfunction drives skin inflammation via formylpeptide receptor 1.
    Br J Dermatol. 2024;190:e45.
    >> Share


  403. 2024 British Skin Foundation Small Grants are NOW AVAILABLE.
    Br J Dermatol. 2024;190:603.
    >> Share


  404. Comparison of topical permethrin 5% and benzyl benzoate 25% for treating scabies.
    Br J Dermatol. 2024;190:e39.
    >> Share


  405. Global consensus process to establish a core dataset for hidradenitis suppurativa registries.
    Br J Dermatol. 2024;190:e42.
    >> Share


  406. The relationship between paediatric eczema and cognition.
    Br J Dermatol. 2024;190:e41.
    >> Share


  407. A guide to using the core outcome set for eczema.
    Br J Dermatol. 2024;190:e44.
    >> Share

  408. GARMAN KA, Thoreson N, Strong J, Hallaert P, et al
    Mycophenolate mofetil inhibits Merkel cell carcinoma growth.
    Br J Dermatol. 2024;190:593-595.
    >> Share

  409. CORNMAN HL, Whang KA, Ma E, Aggarwal P, et al
    Severity, impact on quality of life and mental health burden of pruritus in prurigo nodularis: a cross-sectional study of a diverse patient cohort.
    Br J Dermatol. 2024;190:571-572.
    >> Share

  410. CLAIRE FULLER L, Sunderkotter C
    Scabies therapy update: Should 25% benzyl benzoate emulsion be reconsidered as a first-line agent in classical scabies?
    Br J Dermatol. 2024;190:459-460.
    >> Share

  411. NIELSEN W, Drucker AM
    The need and benefit of the Harmonising Outcome Measures for Eczema user's guide.
    Br J Dermatol. 2024;190:462-463.
    >> Share

  412. XIE W, Kong X, Zheng H, Mei H, et al
    Rapid emergence of recalcitrant dermatophytosis caused by a cluster of multidrug-resistant Trichophyton indotineae in China.
    Br J Dermatol. 2024;190:585-587.
    >> Share

  413. NANDA A, Chang YH, Cheng HC, Lai IT, et al
    Autosomal recessive plantar keratoderma with ragged periungual hyperkeratosis caused by a homozygous missense variant in KRT16.
    Br J Dermatol. 2024;190:588-590.
    >> Share

  414. COWPER R
    For itch and insanity.
    Br J Dermatol. 2024;190:568.
    >> Share

  415. BARLOW R, Ahmed A, Fellows J, Goulding J, et al
    Assessing and managing the mental health of people with vitiligo: a UK-wide consultation exercise.
    Br J Dermatol. 2024;190:574-576.
    >> Share

  416. MEYERSBURG D, Hoellwerth M, Brandlmaier M, Handisurya A, et al
    Comparison of topical permethrin 5% vs. benzyl benzoate 25% treatment in scabies: a double-blinded randomized controlled trial.
    Br J Dermatol. 2024;190:486-491.
    >> Share

  417. MOSCARELLA E, Di Brizzi EV, Alpi P, Arcelli A, et al
    Indications for adjuvant radiotherapy in high-risk cutaneous squamous cell carcinoma with clear margins: a Delphi consensus.
    Br J Dermatol. 2024;190:578-579.
    >> Share

  418. DONHAUSER T, Gabes M, Ozkan E, Masur C, et al
    What do Hyperhidrosis Quality of Life Index (HidroQoL(c)) scores mean? Transferring science into practice by establishing a score banding system.
    Br J Dermatol. 2024;190:519-526.
    >> Share

  419. WAINMAN HE, Chandran NS, Frew JW, Garg A, et al
    Global consensus process to establish a core dataset for hidradenitis suppurativa registries.
    Br J Dermatol. 2024;190:510-518.
    >> Share

  420. GEORGE CD, Lee T, Hollestein LM, Asgari MM, et al
    Global epidemiology of actinic keratosis in the general population: a systematic review and meta-analysis.
    Br J Dermatol. 2024;190:465-476.
    >> Share

  421. NALDI L, Cassalia F
    Actinic keratosis epidemiology: the good, the bad and the ugly.
    Br J Dermatol. 2024;190:457-458.
    >> Share

  422. OYESIKU L, Dlova N, Ahmed S, Owen DR, et al
    Inclusive and equitable language for skin colour in the British Journal of Dermatology: acknowledging our past and laying the foundations to move forward.
    Br J Dermatol. 2024 Mar 13:ljae064. doi: 10.1093.
    >> Share

  423. AALA WJF, Hou PC, Hong YK, Lin YC, et al
    Dominant dystrophic epidermolysis bullosa is associated with glycolytically active GATA3+ Th2 cells which may contribute to pruritus in lesional skin.
    Br J Dermatol. 2024 Mar 13:ljae110. doi: 10.1093.
    >> Share


  424. Correction to: Malignancy risk in patients with atopic dermatitis: a population-based cohort study.
    Br J Dermatol. 2024 Mar 12:ljae093. doi: 10.1093.
    >> Share

  425. CANTISANI C, Taliano A, Longo C, Bortone G, et al
    Dynamic Optical Coherence Tomography and Reflectance Confocal Microscopy of Basal Cell Carcinoma of the Nipple-Areola Complex.
    Br J Dermatol. 2024 Mar 12:ljae104. doi: 10.1093.
    >> Share

  426. ARMATO U, Dal Pra I
    Discovering skin-rejuvenating matrikines - a basic and applied Dermatology new frontier.
    Br J Dermatol. 2024 Mar 12:ljae100. doi: 10.1093.
    >> Share

  427. CHEN GF, Xu S, White MA, Cohen JM, et al
    Association between atopic dermatitis and eating disorders: a cross-sectional study in the All of Us Research Program.
    Br J Dermatol. 2024 Mar 11:ljae103. doi: 10.1093.
    >> Share

  428. RA AG, Littlewood Z, Barton A, Keevil B, et al
    The use of serum methotrexate level as an assessment of biochemical drug adherence in psoriasis.
    Br J Dermatol. 2024 Mar 8:ljae096. doi: 10.1093.
    >> Share

  429. REHBINDER EM, Warnberg Gerdin S, Hoyer A, Bradley M, et al
    Frequent oil-baths and skin barrier during infancy in the PreventADALL study.
    Br J Dermatol. 2024 Mar 6:ljae091. doi: 10.1093.
    >> Share

  430. EL HACHEM M, De Marco R, Soria de Francisco JM, Audouze A, et al
    Ichthyosis: multinational European study on patient characteristics and body sites involved with impact on quality of life.
    Br J Dermatol. 2024 Mar 1:ljae082. doi: 10.1093.
    >> Share

    February 2024
  431. RIBERO S, Quaglino P, Roccuzzo G
    Unveiling cutaneous adverse events and prognosis in immunotherapy for melanoma and squamous cell carcinoma.
    Br J Dermatol. 2024 Feb 29:ljae092. doi: 10.1093.
    >> Share

  432. RAMESSUR R, Dand N, Langan SM, Saklatvala J, et al
    Defining disease severity in atopic dermatitis and psoriasis for the application to biomarker research- an inter-disciplinary perspective.
    Br J Dermatol. 2024 Feb 29:ljae080. doi: 10.1093.
    >> Share

  433. GREVE AM, Wulff AB, Bojesen SE, Nordestgaard BG, et al
    Elevated plasma triglycerides increase risk of psoriasis: A cohort and Mendelian randomization study.
    Br J Dermatol. 2024 Feb 27:ljae089. doi: 10.1093.
    >> Share

    January 2024
  434. SAAD R, Duipmans J, Yerlett N, Plevey K, et al
    Neonatal Epidermolysis Bullosa: a clinical practice guideline.
    Br J Dermatol. 2024 Jan 4:ljae006. doi: 10.1093.
    >> Share

    December 2023
  435. FORKEL S, Schubert S, Corvin L, Heine G, et al
    Contact allergies to dental materials in patients.
    Br J Dermatol. 2023 Dec 20:ljad525. doi: 10.1093.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016